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Abstract 
During chronic and severe acute liver injury, regeneration is thought to occur through 
hepatic progenitor cells (HPCs). Understanding the regulation of HPCs may offer 
therapeutic opportunities to enhance liver regeneration. HPCs are associated with an 
increase in laminins in the extracellular matrix. Laminins are heterotrimeric proteins, 
composed of an alpha, beta and gamma chain. There are 5 alpha chains with different 
distributions and functions, but the relative contributions of these in HPC-mediated 
liver regeneration are not known. My aims were to describe the laminin alpha chains 
associated with the HPC response and to define the functional effects of specific 
laminin chains on HPCs. 
I examined the laminin alpha chains in two mouse models of HPC activation: a 
transgenic model using conditional deletion of Mdm2 in hepatocytes, and a dietary 
model using 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC). The laminin alpha 5 
(Lama5) chain is significantly upregulated in both models and forms a basement 
membrane which surrounds the progenitor cells. I have also demonstrated Lama5 
expression in the ductular reaction seen in human liver disease. Using primary mouse 
cell cultures, I have shown that Lama5 is produced predominantly by the HPCs 
themselves, rather than by stellate cells. The HPCs express the cell surface receptor 
alpha-6 beta-1 integrin, a binding partner of Lama5. 
I then studied the functional effects of matrix on cell behaviour in vitro using 
recombinant laminins and a line of spontaneously immortalised mouse HPCs. 
Compared to other laminin chains, Lama5 selectively promotes HPC adhesion and 
spreading. These effects are partially blocked by antibodies against beta-1 integrin. 
Lama5 also significantly enhances HPC migration, resulting in an increase in cell 
migration. Furthermore, only Lama5 enhances HPC survival in serum-free medium, 
with an increase in cell viability. Culturing HPCs on HPCs maintained in culture on 
plastic synthesise Lama5 chain. Knock-down of endogenous Lama5 production 
using siRNA results in reduced proliferation and increased hepatocytic 
differentiation, with increased albumin production. 
 
  iii 
I then studied the effects in vivo using transgenic Cre-lox mouse strains that allow 
conditional knock-out of either laminin alpha 5 or beta-1 integrin in HPCs. The 
effects of gene deletion were examined in healthy mice and two dietary models of 
HPC activation: the DDC diet and a choline-deficient, ethionine-supplemented 
(CDE) diet. Although these experiments were limited by a low number of 
experimental animals and low recombination rates, there was a suggestion of 
impaired HPC expansion associated with loss of laminin alpha 5. There was also a 
significant increase in hepatocellular injury and fibrosis in response to the DDC diet 
seen with loss of laminin alpha 5 expression.  
Laminin alpha 5-containing matrix is deposited around HPCs during liver 
regeneration and supports progenitor cell attachment, migration and maintenance of 
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Chapter 1: Introduction 
 
The liver has key roles in nutrient metabolism, detoxification, serum protein 
synthesis and bile secretion. It has a dual blood supply, receiving arterial inflow from 
the hepatic artery and blood from the intestine and spleen via the portal vein. The 
latter is a source of not only nutrients but also toxins and drugs. The liver is therefore 
the primary barrier to many forms of injury. Perhaps for this reason, the liver has a 
remarkable regenerative capacity.  
Despite the liver’s ability to regenerate, however, liver disease is the 5th most 
common cause of death in the United Kingdom and deaths from cirrhosis are rapidly 
rising, even amongst 15-44 year olds (Leon and McCambridge, 2006). A recent 
population-based study estimated that the incidence of cirrhosis increased by around 
50% over the 12 year period from 1998 to 2009 (Ratib et al., 2014). Cirrhosis can 
arise in response to a wide range of chronic insults, including alcohol, viral hepatitis, 
fatty liver, autoimmune diseases and inherited metabolic conditions. Orthotopic liver 
transplantation is currently the only effective treatment for end-stage cirrhosis or 
severe acute liver failure. Transplantation is severely limited by donor organ 
availability and is associated with significant complications related to operative risk, 
long-term immunosuppression and rejection. There is therefore an urgent need for 
alternative treatments for chronic liver disease. Understanding the mechanisms that 
control liver regeneration may allow novel strategies to enhance endogenous liver 
regeneration.  
1.1 Liver regeneration 
Mechanisms of liver regeneration 
The liver is unusual in its ability to regenerate from both mature cells and facultative 
stem cells, as shown diagrammatically in figure 1.1 (Duncan et al., 2009, Fausto, 
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Figure 1.1 Pathways of liver regeneration 
Following partial hepatectomy or acute hepatocellular injury, mature hepatocytes are 
able to re-enter the cell cycle and divide to restore the functional hepatocyte mass. 
Following chronic or severe acute injury, however, this mechanism appears to be 
impaired and hepatic progenitor cells (HPCs) located in the terminal bile ducts are 
able to expand and differentiate into hepatocytes instead. These HPCs are also 
capable of differentiating into biliary epithelial cells in the context of biliary injury.   
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Following surgical removal of up to two-thirds of the liver, the remaining uninjured 
liver is able to regenerate efficiently through division of mature hepatocytes (Higgins 
and Anderson, 1931, Michalopoulos, 2007). A similar mechanism is seen after acute 
toxic injury with acetaminophen or carbon tetrachloride (Lee et al., 1998). More 
recently, it has been shown that hepatocyte enlargement rather than simply division 
is also able to contribute significantly to recovery from acute liver injury (Miyaoka et 
al., 2012). Although hepatocyte-mediated regeneration is the predominant 
mechanism seen following partial hepatectomy, there is evidence that the ability of 
mature hepatocytes to replicate becomes compromised in advanced liver disease. In 
rodent models of fibrosis and cirrhosis, there is a reduction in hepatocyte DNA 
synthesis in response to partial hepatectomy (Kato et al., 2005, Kanta and Chlumska, 
1991). Similarly in human cirrhosis, hepatocytes express markers of cell cycle arrest, 
suggesting that their ability to contribute to regeneration is impaired (Marshall et al., 
2005).  
After severe or chronic injury, therefore, it has been proposed that regeneration 
occurs through activation of a resident liver stem cell. This produces hepatic 
progenitor cells (HPCs) which are bipotential, capable of differentiating into either 
hepatocytes or biliary epithelial cells (Evarts et al., 1989, Forbes et al., 2002, 
Santoni-Rugiu et al., 2005, Vig et al., 2006). As these cells are only seen under 
certain conditions, they have also been referred to as facultative liver stem cells.  
Some researchers have also suggested a potential contribution from mesenchymal 
cells to hepatocyte formation, via mesenchymal-epithelial transformation. Both glial 
fibrillary acidic protein (GFAP)-expressing cells and alpha smooth muscle actin 
(SMA)-expressing cells have been shown to contribute to hepatocytes under certain 
conditions (Yang et al., 2008, Swiderska-Syn et al., 2013). However, a recent lineage 
tracing report that marked nearly all hepatic stellate cells showed no evidence of 
epithelial progenitor function across a wide range of liver injury models (Mederacke 
et al., 2013).  
In addition to hepatocyte self-renewal and HPC-mediated regeneration, recent work 
in cellular reprogramming has also suggested a greater degree of plasticity in liver 
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cell fate than was previously thought. Activation of Notch signalling within mature 
hepatocytes is capable of converting them into biliary epithelial cells, and lineage 
tracing studies suggest that this may occur spontaneously during biliary injury 
(Yanger et al., 2013). Similarly, ectopic activation of the Hippo/YAP pathway in 
hepatocytes results in de-differentiation and adoption of an HPC phenotype 
(Yimlamai et al., 2014). These studies suggest that the relationship between HPCs, 
hepatocytes and biliary epithelial cells may be more complex than we thought. 
 
Defining hepatic progenitor cells 
During fetal liver development, the foregut endoderm gives rise to a population of 
hepatoblasts, which can differentiate into both hepatocytes and biliary epithelial cells 
(Lemaigre, 2009). These fetal progenitors express the markers Dlk, E-cadherin and 
Liv2 (Tanimizu et al., 2003, Nitou et al., 2002, Watanabe et al., 2002). No cells 
equivalent to the fetal hepatoblast are seen in healthy adult liver. However, during 
regeneration after certain types of liver injury, a related cell emerges. 
Oval cells, a population of small cells with an ovoid nucleus and a high nuclear-to-
cytoplasmic ratio, were initially described in the portal areas of rat livers after 
chemical injury (Shinozuka et al., 1978, Sell, 1978). These cells were noted to co-
express markers of hepatocytes (albumin) and biliary epithelial cells (keratin-19) in a 
similar manner to the fetal hepatoblasts, leading to speculation that oval cells may be 
common precursors for both lineages in the injured adult liver. These form ductular 
structures extending from the terminal biliary ductules (Paku et al., 2001). Similar 
but not identical cells are also seen in mice (Jelnes et al., 2007).  
Cells with similar characteristics have also been seen in humans and have been called 
hepatic progenitor cells, or HPCs. The term ductular reaction (DR) refers to the 
proliferation of biliary epithelial cells (which are assumed to contain the hepatic 
progenitor cells) and the associated inflammatory reaction seen across a wide range 
of liver injuries. Three-dimensional reconstructions of the liver show that these cells 
arise from the interface between the hepatocyte canalicular system and the biliary 
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tree, known as the canals of Hering (Theise et al., 1999). This location is consistent 
with a common progenitor. 
Although there are many similarities between fetal hepatoblasts and adult HPCs, it 
should not be assumed that the two will behave identically and care should be taken 
when discussing “liver stem (or progenitor) cells” to specify whether this is fetal or 
adult. In my thesis, I will use the term HPC to indicate only the adult hepatic 
progenitor cell.  
 
Animal models of hepatic progenitor cells 
A variety of animal models have been used to study HPCs. Progenitor-mediated 
regeneration has been modelled in the rat by combining with partial hepatectomy 
with chemical inhibition of hepatocyte proliferation using 2-acetylaminofluorene (2-
AAF) or retrorsine (Laishes and Rolfe, 1981, Evarts et al., 1989). Although effective 
in inducing a progenitor cell response, the surgery was associated with pain, 
increased mortality and numerous changes in the physiological state of the animals. 
A similar oval cell response is seen in rats in response to the hepatotoxins D-
galactosamine (Lemire et al., 1991) and allyl alcohol (Yin et al., 1999).  
In mice, however, partial hepatectomy and 2-AAF fails to produce convincing 
activation of HPCs (Jelnes et al., 2007). Instead, several dietary or toxin models of 
mouse progenitor cell activation have been described:  the choline-deficient, 
ethionine supplemented (CDE) diet (Akhurst et al., 2001), the 3,5-diethoxycarbonyl-
1,4-dihydro-collidine-supplemented (DDC) diet (Wang et al., 2003) and 
phenobarbital/cocaine (Rosenberg et al., 2000). HPCs have also been shown after 
genetic induction of senescence in hepatocytes (Endo et al., 2012). 
A novel transgenic mouse model has recently been described by our group which 
induces hepatic progenitor cells by conditional deletion of the Mdm2 gene in 
epithelial cells (Lu et al, under review). As this model induces very large numbers of 
HPCs within a short time period, it represents a useful model in which to study the 
laminin-progenitor cell interaction. Cyclic recombinase (Cre) is expressed under the 
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control of a cytochrome p450 promoter which is usually transcriptionally silent but is 
up-regulated in epithelial tissues in response to the xenobiotic beta-naphthoflavone, 
acting via the aryl hydrocarbon (Ah) receptor (Ireland et al., 2004). Mice carrying the 
AhCre transgene on a C57/Bl6 background were crossed with mice homozygous for 
the floxed murine double minute 2 (Mdm2) gene, a negative regulator of the tumour 
suppressor gene p53 (Grier et al., 2002). Uninduced animals develop normally until 
exposure to beta-naphthoflavone results in activation of Cre in epithelial tissues, with 
consequent loss of mdm2 and upregulation of p53. In the liver, this results in 
hepatocyte senescence and apoptosis, with a florid hepatic progenitor cell response.  
 
 
Identification of progenitor cells 
The distinction between stem cells and progenitor cells can be unclear at times 
(Tajbakhsh, 2009). The key properties of an adult stem cell are generally accepted to 
be the capacity for long-term self-renewal, and the ability for its progeny to 
differentiate into some or all of the main cell types within that organ. HPCs are 
thought to represent a transit amplifying population of proliferating committed 
progenitors that are not necessarily self-renewing. The identity of the presumed 
underlying self-renewing stem cell is not clear.  
Attempts to identify putative HPCs have assessed both proliferation using clonogenic 
assays and the ability to differentiate towards hepatocytic and biliary lineages 
(Dorrell et al., 2011). The regenerative capacity of HPCs can also be assessed in vivo 
using liver repopulation assays (Wang et al., 2003, Suzuki et al., 2008). 
One of the limitations of studies using adult liver progenitor cells is their lack of 
specific cell surface markers. Historically, progenitor cells were identified in tissue 
on the basis of morphology and location, as well as co-expression of hepatocytic and 
biliary markers. When attempting to isolate cells, however, there is no consensus 
between investigators on the molecular signature of the liver progenitor cell and no 
unique cell surface marker has been identified (Dolle et al., 2010). Many of the 
markers traditionally used to identify LPCs such as OV-6, keratin-19 (K19), 
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pancytokeratin (panCK) and Epithelial Cell Adhesion Molecule (EpCAM) are also 
expressed on mature cholangiocytes.  
Epithelial Cell Adhesion Molecule (EpCAM) is a marker expressed on fetal 
hepatoblasts (Suzuki et al., 2000). EpCAM-positive cells derived from adult mouse 
liver can be differentiated into both lineages in culture (Suzuki et al., 2008, Okabe et 
al., 2009) and are capable of repopulating both hepatocytes and cholangiocytes in a 
transplant model (Yovchev et al., 2008).  
Some markers usually associated with haematopoietic cells have also been 
demonstrated on hepatic progenitor cells. CD133+ CD45- cells coexpress markers of 
both hepatocytes and biliary epithelial cells and be differentiated into both lineages 
in culture (Rountree et al., 2007). CD13+ CD133+ CD49f+ cells from postnatal 
livers can differentiate into hepatocyte-like and cholangiocyte-like cells under 
appropriate culture conditions and have been shown to undergo self-renewal-like 
activity in serial sorted culture (Kamiya et al., 2009). 
CD24 is expressed on both biliary epithelial cells and oval cells seen in the DDC 
model, and is associated with other progenitor markers such as K19 and EpCAM. 
CD24+ CD45- cells from adult liver have been shown to form hepatocytes in a 
transplantation model (Qiu et al., 2011).  
More recently, a novel antibody identified by Markus Grompe’s group (MIC1-1C3) 
is capable of isolating a population that contains clonogenic cells capable of 
generating both hepatocytes and biliary epithelial cells (Dorrell et al., 2011).  
However, these markers are all expressed on normal uninjured bile ducts or 
haematopoietic cells and are not specific for progenitor cells. There is therefore no 
current marker which allows isolation of a pure hepatic progenitor cell population.  
Small hepatocytes have been isolated from rat livers using selective culture 
conditions, which can be differentiated into mature hepatocytes and may represent an 
intermediate step in the differentiation of progenitor cells (Mitaka et al., 1999). 
CK19-positive and OV-6-positive cells are identified as the likely source of small 
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hepatocyte-like progenitors in rats treated with retrorsine/partial hepatectomy (Chen 
et al., 2013).  
In humans, an equivalent hepatic progenitor cell population has been identified 
within the biliary tree that can form both hepatocytes and bile duct cells. These 
progenitors express EpCAM, NCAM, CXCR4 and CD44 (Cardinale et al., 2011). 
In reality, there may be a range of overlapping phenotypes, from the most immature 
bipotential transit-amplifying cell through varying stages of commitment to either 
lineage (Sell, 1998). Ductular reactions in cirrhotic human livers have been shown to 
have distinct polarity, with hepatocytic and biliary differentiation at either end (Zhou 
et al., 2007). Indeed, some authors have described at least 8 stages of lineage 
maturation from stem cell through to fully mature pericentral hepatocyte (Turner et 
al., 2011). There are therefore likely to be differences in the behaviour of progenitor 
cells according to the marker used and the model from which the cells are obtained. 
 
Relative contributions of hepatocytes and HPCs to liver regeneration 
In order to study liver regeneration and the relative contributions of hepatocytes and 
HPCs, several techniques have been used. One early method for studying stem cells 
in other organs has been the label retention assay, in which a DNA marker such as 
tritiated thymidine or bromodeoxyuridine (BrdU) is incorporated by dividing cells. 
This label becomes gradually diluted by serial divisions in proliferating cells but 
remains detectable in slowly-dividing stem cells.  
Tritiated thymidine labelling of dividing cells in the uninjured rat liver showed a 
gradual migration of labelled cells over several weeks from the periportal region 
towards the hepatic vein, suggesting hepatocyte turnover from a periportal source 
(Zajicek et al., 1985). This has been termed the “streaming liver” hypothesis. 
However, this is contradicted by an alternative study using retroviral labelling after 
partial hepatectomy, which did not demonstrate any migration of labelled cells 
(Bralet et al., 1994).  
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One of the difficulties with label-retaining studies in the uninjured liver is the slow 
rate of normal hepatocyte turnover, with BrdU incorporation rates of less than 1 in 
20,000 cells. This technique has therefore been used in combination with repeated 
injury with paracetamol in mice, to increase turnover and stimulate regeneration 
(Kuwahara et al., 2008). This suggested 4 possible locations of label-retaining cells, 
including the terminal branches of the biliary tree (known as canals of Hering), the 
intralobular bile duct, the periductal monocyte and peribiliary hepatocyte. Work in 
the haematopoetic stem cell field, however, has suggested that BrdU label retention 
has a poor sensitivity and specificity for identifying stem cells (Kiel et al., 2007). 
There is now evidence from animal models using genetic lineage tracing that HPCs 
can contribute, albeit modestly, to functional hepatocytes during injury. Using an 
osteopontin-linked Cre to label HPCs, it was shown that up to 3.26% of all 
hepatocytes were derived from progenitors in the CDE diet model (Espanol-Suner et 
al., 2012). This same study found a negligible contribution from HPCs to hepatocytes 
during normal liver homeostasis, after partial hepatectomy or carbon tetrachloride 
injury. Another lineage tracing study labelled hepatocytes using an adenoviral-
associated vector-linked Cre (Malato et al., 2011). This showed that after chronic 
carbon tetrachloride injury, 1.3% of hepatocytes were derived from a non-hepatocyte 
source, presumed to represent HPCs. Again, there was little contribution to 
homeostasis after acute resection or toxic injury.  
Although these numbers represent a minor proportion of mature hepatocytes, the 
injury models used are mild and short-term compared with chronic liver disease in 
humans. Further lineage tracing or transplantation experiments are required to 
determine the true functional regenerative capacity of HPCs over prolonged, repeated 
or severe liver injury that closely models human disease. 
In humans, there is indirect evidence to suggest a lineage connection between HPCs 
and hepatocytes. Intraseptal hepatocytes in cirrhosis are strongly associated with 
K19-positive ductular reactions and can be shown by three-dimensional 
reconstructions to link to the biliary tree (Falkowski et al., 2003). Even in the 
uninjured human liver, non-pathogenic mutations in mitochondrial DNA have been 
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used to demonstrate clonal patches of hepatocytes abutting portal tracts and 
extending laterally towards the central veins (Fellous et al., 2009). Although this 
study is limited to single time points and so cannot demonstrate with certainty the 
direction of spread of these mutations, it does suggest that hepatocytes may be 
originating from a periportal source. Clearly, however, this does not identify the 
underlying cell of origin, and could be explained by the division of mature periportal 
hepatocytes just as readily as HPCs.  
Hepatocytes that are positive for EpCAM are found close to ductular reactions and 
have a longer telomere length than EpCAM-negative hepatocytes, suggesting their 
origin from a slow-cycling stem cell (Yoon et al., 2011). However, the interpretation 
of this study relies on the assumption that EpCAM-positive hepatocytes have 
recently differentiated from HPCs, rather than having acquired EpCAM expression. 
It could be argued rather that biologically younger hepatocytes (as indicated by 
telomere length) may have greater plasticity to allow them to acquire EpCAM 
expression when exposed to paracrine signalling from a nearby ductular reaction. In 
short, the evidence for a functional role of HPCs in liver regeneration in humans is 
rather circumstantial, but is inferred from the similarities to HPCs in animal models. 
 
HPCs and cancer 
In addition to their role in regeneration, HPCs have also been implicated in the 
development of liver cancer. It is known that patients with cirrhosis and chronic viral 
hepatitis have an increased risk of developing primary liver cancers. In a series of 
109 cases of hepatocellular cancer (HCC), more than a quarter expressed 
biliary/progenitor cell markers (Keratin-7 and/or Keratin-19), prompting speculation 
that they may have derived from malignant transformation of progenitor cells 
(Durnez et al., 2006). Expression of both hepatocellular and biliary markers does not 
necessarily imply origin from HPCs and could be explained by either de-
differentiation or transdifferentiation. With the advent of a number of lineage tracing 
tools, it will hopefully be possible to answer this question more directly in the future. 
Nevertheless, the idea that dysregulation of HPCs may contribute to the development 
of primary liver malignancies remains a valid concern.  
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1.2 Extracellular matrix and cell behaviour 
Cells in multicellular organisms are surrounded by a complex network of cross-
linked proteins and polysaccharides. The composition of this matrix is dynamic and 
varies widely between tissues during both development and disease. The 
extracellular matrix (ECM) was initially thought of as an inert scaffold which simply 
provided physical support for cells. However, it is now recognised that in addition to 
structure, the matrix plays an important role in regulating cell behaviour (Hynes, 
2009).  
The extracellular matrix consists of a range of macromolecules composed of protein 
and carbohydrate elements. These include glycoproteins which are a predominantly 
protein core with the addition of carbohydrate elements, and proteoglycans which are 
mainly carbohydrate with some protein elements (Sharon, 1986). The main structural 
proteins include collagens which form helical fibrils that provide tensile strength, 
elastin which is heavily cross-linked to provide recoil, and laminins which can 
polymerise to form sheets. Glycoproteins such as fibronectin, nidogen and perlecan 
can form links between these main protein networks and also interact directly with 
cells themselves. In contrast, the proteoglycans bind large amounts of water and form 
a gel-like matrix. They are described according to the main disaccharides present 
(chondroitin, keratin, dermatin, heparin and hyaluronan) and their sulfation status. 
These molecules can combine to form two main types of ECM: the thin dense 
basement membrane that underlies all epithelial cells, and the loose trabecular 
interstitial matrix that exists in the spaces between cells. Basement membranes are 
typically rich in laminin, type IV collagen, nidogen and perlecan, whereas interstitial 
matrix contains predominantly type I collagen, fibronectin and proteoglycans.  
In contrast to all other epithelial tissues, the liver lacks a clearly-defined basement 
membrane underlying hepatocytes. Laminin-rich basement membranes occur around 
blood vessels and bile ducts but the normal liver parenchyma is almost devoid of 
laminins (Hahn et al., 1980). Instead, the gap between hepatocyte and endothelial 
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cell, known as the Space of Disse, has a sparse matrix composed mainly of 
fibronectin and type I collagen (Martinez-Hernandez and Amenta, 1993).  
 
HPCs and the niche 
The behaviour of stem cells has been shown to be critically influenced by their 
microenvironment, or niche (Voog and Jones, 2010, Fuchs et al., 2004).  Within the 
niche, a stem cell may have direct contact with either a basal lamina or another cell 
type which are critical for their maintenance and function. The expression of high 
levels of cell-cell and cell-matrix adhesion molecules by mammalian stem cells is 
well-described, but the specific functions of these molecules are poorly understood 
(Marthiens et al., 2010). The stem cell niche is well-described in organs such as the 
bone marrow, brain, skin and intestine but not in liver. 
HPCs are found in close association with a niche composed of other cells, including 
hepatic stellate cells and macrophages, and extracellular matrix (Kordes and 









Introduction  15 
Figure 1.2 The hepatic progenitor cell niche 
HPCs are located in the periportal region, arising from the canals of Hering. They are 
surrounded by an extracellular matrix rich in laminins and collagens. The laminin 
forms a basement membrane around the cells, and the collagen is located in front of 
the HPCs along the portovenous gradient as they migrate into the lobule. In close 
proximity, there are hepatic stellate cells (HSCs) and the resident liver macrophages 
(Mφs), or Kupffer cells. These cells may be important in influencing the matrix 
composition as well as providing direct cell-cell signalling.  
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The niche cells can influence HPCs directly via Wnt and Notch signalling (Boulter et 
al., 2012), but both stellate cells and macrophages can also alter the composition of 
the extracellular matrix. Hepatic stellate cells are the main matrix-producing cells of 
the liver (Maher et al., 1988, Arenson et al., 1988) and also produce matrix 
metalloproteinases (MMPs) and their inhibitors that regulate matrix degradation 
(Benyon and Arthur, 2001). Hepatic macrophages have been shown to be a source of 
MMPs during liver injury and regeneration (Knittel et al., 1999, Fallowfield et al., 
2007). In chronic hepatitis C, macrophages expressing MMP-9 were confined to a 
portal subpopulation and their numbers correlated with portal fibrosis (Gadd et al., 
2013). In addition, the HPCs themselves appear to be capable of matrix synthesis, at 
least in vitro (Lorenzini et al., 2010), and can produce MMPs (Pham Van et al., 
2008). There are therefore a number of potential mechanisms for dynamic changes in 
matrix around HPCs during regeneration.  
 
HPCs and matrix 
There are strong associations between HPCs/DRs and changes in the matrix content 
of the liver (Zhu et al., 2012, Williams et al., 2014). In human liver disease, the 
ductular reaction correlates with the severity of fibrosis across a range of liver 
pathologies, including chronic hepatitis C, alcoholic and non-alcoholic 
steatohepatitis, and genetic haemochromatosis (Lowes et al., 1999, Clouston et al., 
2005, Roskams et al., 2003, Wood et al., 2013).  
Hepatic progenitor cells in rodent models are also associated with changes in matrix, 
and these models allow the link to be explored in more detail. In the mouse CDE 
dietary model of progenitor cell expansion, there is rapid upregulation of collagen I 
and laminin at a messenger RNA level, and an increase in Sirius Red staining (which 
stains collagens I and III) in the periportal area (Van Hul et al., 2009).  
In the rat 2AAF/partial hepatectomy model, the liver progenitor cells are in direct 
contact with a basement membrane containing laminin, which is virtually absent 
from the normal liver sinusoids and disappears again following regeneration (Paku et 
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al., 2001). Laminin has also been demonstrated in association with progenitor cells in 
transgenic mice that express hepatitis B protein and were treated with retrorsine 
(Lorenzini et al., 2010) or mice treated with chronic carbon tetrachloride (Kallis et 
al., 2011). In humans, laminin has been shown to associate with progenitor cells in 
patients with chronic hepatitis B or C infection (Lorenzini et al., 2010).  
The transition from progenitor cell to hepatocyte appears to correlate with the loss of 
contact with this basement membrane (Paku et al., 2004). Cells in contact with the 
basement membrane had low levels of the hepatocytic transcription factor 
Hepatocyte Nuclear Factor 4 (HNF4), whereas cells that lacked contact showed 
upregulation of HNF4.  
The laminin is localised to areas of progenitor cell expansion. Transgenic mice that 
express urokinase-type plasminogen activator under the control of the albumin 
promoter (Alb-uPA) develop spontaneous liver injury, with evidence of a progenitor 
cell response (Braun et al., 2003). As the mice age, there is gradual emergence of 
clonal patches of hepatocytes which have lost expression of the transgene, resulting 
in mosaicism. Progenitor cells are restricted to areas of uPA-positive hepatocytes, 
and the extracellular laminin deposition is similarly localised.  
In addition to changes in collagen and laminin, there is also a rapid increase in 
fibronectin following 2-AAF and partial hepatectomy. However, this is seen 
throughout the liver lobule and although fibronectin is found in association with the 
progenitor cells, it also has a much wider distribution beyond this (Zhang et al., 
2009). 
There is also indirect work to suggest a role for the matrix proteoglycan hyaluronan 
in HPC regulation. A number of proteoglycans including hyaluronan are over-
expressed in cirrhosis (Murata et al., 1984). Rat small hepatocytes (an intermediate 
stage in the differentiation of HPCs towards hepatocytes) express the hyaluronan 
receptor CD44s (Chiu et al., 2009). When cultured on hyaluronan, the proliferation 
of small hepatocytes correlated with CD44s expression. However, when 
 
Introduction  18 
differentiation was induced using Matrigel, CD44s expression was lost (Kon et al., 
2006).  
 
Chicken or egg? 
It is clear then that a number of changes in the extracellular matrix accompany the 
proliferation and subsequent differentiation of HPCs, with altered levels of collagens, 
laminins and proteoglycans. However, it is not clear what role this plays in the 
regulation of the HPCs. Are matrix changes required to directly regulate HPCs, or 
are the matrix changes simply a consequence of HPC expansion or even a parallel 
response to injury? Is fibrosis beneficial for HPC-mediated regeneration or is fibrosis 
unintentionally exacerbated by the progenitor reaction (Clouston et al., 2009)? These 
questions clearly have major implications for both pro-regenerative and anti-fibrotic 
therapies. 
In the CDE mouse model discussed earlier (Van Hul et al., 2009), the increase in 
Sirius Red staining is demonstrable as early as day 3 whereas the appearance of 
significant numbers of HPCs was only seen by day 7. Furthermore, the collagen I 
appears to precede the progenitor cells along the porto-venous gradient as they 
migrate into the liver lobule. This suggests that the matrix changes may be required 
for HPC expansion. 
As well as a temporo-spatial association between progenitor cells and matrix, there is 
also evidence that impaired regeneration is associated with reduced matrix changes. 
Using an inbred strain of BALB/c mice that have deficient T-cell signalling, the 
reduced number of HPCs seen in response to the CDE diet was associated with a 
reduction in the amount of liver collagen, as assessed by Sirius Red staining (Knight 
et al., 2007a). Similarly, enhancing the regenerative response to the CDE diet by 
giving interferon gamma increases both the number of HPCs and the amount of liver 
fibrosis (Knight et al., 2007b). However, it is not clear from these studies whether the 
matrix changes are necessary for, or occur as a result of, progenitor cell activation.  
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Evidence for a functional effect of laminin on HPC behaviour comes from an in vitro 
study (Lorenzini et al., 2010). CD45-depleted non-parenchymal cells isolated from 
mice on the CDE diet were cultured for 7 days under conditions that positively select 
for HPCs. The resulting cells were small and rounded with a high nuclear-to-
cytoplasmic ratio and demonstrated positive staining with a pancytokeratin antibody. 
These cells remained positive for pancytokeratin staining when cultured for 7 days 
on laminin, but lost this on collagen I, collagen IV or fibronectin. Cells cultured on 
laminin also upregulated gene expression of biliary markers (GGT, aquaporin) and 
downregulated the hepatocytic transcription factor C/EBP alpha. In contrast, 
fibronectin led to hepatocytic differentiation, as demonstrated by cytochrome p450 
staining. This supports the hypothesis that contact with laminin is necessary for adult 
HPCs to maintain a naive phenotype, and suggested that fibronectin may be 
important in promoting differentiation. 
Extracellular matrix has also been used a factor to aid the differentiation of human 
liver progenitors in vitro. Human HPCs cultured on a matrix containing a mixture of 
collagen IV and laminin adopted a hepatocytic fate, whereas those cultured on 
collagen I resembled biliary cells (Cardinale et al., 2011). Although this supports the 
idea that matrix can contribute to cell fate, it should be noted though that there were 
also significant differences between the media used in these two groups, making it 
impossible to determine the relative contribution of the matrix to this process. 
Perhaps the strongest in vivo evidence so far of an effect of matrix on progenitor cell 
function comes from a recent lineage tracing experiment (Espanol-Suner et al., 
2012). This used an inducible Cre recombinase under the control of osteopontin to 
selectively label progenitor/biliary cells and demonstrate differentiation into 
hepatocytes. This model was used to study the effects of Iloprost, a prostacyclin 
analogue that causes a reduction in connective tissue growth factor (CTGF) 
production with a subsequent reduction in matrix deposition (Pi et al., 2005). When 
Iloprost was given during the CDE diet, there was a reduction in both the collagen 
and laminin content of the liver. This was associated with a reduction in the number 
of progenitor/biliary cells and an increase in the number of progenitor-derived 
hepatocytes, suggesting premature differentiation. Although the authors argue that 
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the reduction in HPCs is due to the altered matrix, it is known that Iloprost has other 
effects on stellate cells (Kawada et al., 1992). It is therefore possible that Iloprost 
may be having other direct cellular effects rather than necessarily acting through the 
alteration in matrix.  
As well as matrix influencing HPC behaviour, it has been suggested that HPCs may 
promote fibrosis. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) is 
a mitogen for HPCs, acting via the Fn14 receptor (Jakubowski et al., 2005). A recent 
study showed that administration of recombinant TWEAK to fibrotic mice 
undergoing partial hepatectomy caused an increase in both the number of HPCs and 
the amount of collagen (Kuramitsu et al., 2013). The authors conclude that HPCs are 
driving the fibrosis. However, there is evidence from other organs that TWEAK acts 
directly on myofibroblasts to promote activation and collagen production 
(Novoyatleva et al., 2013, Dohi and Burkly, 2012). It is therefore possible that 
TWEAK is having parallel effects on myofibroblasts and HPCs.  
 
HPCs and matrix remodelling 
Further insight into the role of collagen in HPC regulation comes from a transgenic 
mouse (r/r mouse) that produces mutated collagen I that is resistant to MMP 
degradation. In the r/r mouse model, liver progenitor cell numbers were reduced 
compared to wild-type mice in response to both chronic carbon tetrachloride injury 
and the CDE diet (Kallis et al., 2011). Although there was an increase in liver 
collagen content in the r/r mouse, the impaired HPC response was associated with a 
reduction in laminin deposition. This suggests that laminin may be more closely 
related to HPCs than collagen. 
The same investigators also showed a non-significant trend towards a reduction in 
progenitor cell numbers in MMP-13 (collagenase) knock-out mice compared to wild-
type mice. This suggests that the presence of collagen I in itself does not promote 
HPC expansion but that rather the turnover of collagen I is required. It remains 
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unclear whether this is due to a physical barrier or is mediated by either growth 
factor release or direct matrix-cell signalling. 
 
1.3 Laminins 
Laminins are a family of large ECM proteins that are a major component of 
basement membranes (Durbeej, 2010). Laminins have been shown to play key roles 
in a range of cell behaviours including survival, migration and differentiation 
(Paulsson, 1992, Colognato and Yurchenco, 2000). 
Laminins are trimers composed of 3 different polypeptide chains, termed α, β and γ 
(Aumailley et al., 2005). Each trimer is composed of one α, one β and one γ chain, as 
shown in figure 1.3. The heterotrimeric proteins are able to further polymerise to 
form continuous sheets, and are the main matrix component in many basement 
membranes. Laminins bind also several other matrix proteins, including nidogen, 
agrin, perlecan, fibulin-1 and fibulin-2, and sulfatides. 
At present, 5α, 4β and 3γ chains are known for mouse and human (Miner and 
Yurchenco, 2004) which represent distinct gene products. These can combine to 
form at least 18 different trimers. Basement membranes will often contain several 
different isoforms in combination. 
A variety of nomenclatures have been used to identify the different laminin isoforms. 
Although each trimer was initially allocated a single number to reflect the order in 
which they were described and some have individual names, it is now recommended 
that they should be referred to by three-digit numbers that reflect their chain 
composition (Aumailley et al., 2005). For instance, the trimer formed by the α3, β3 
and γ2 chains which was formerly known as laminin-5 or kalinin is laminin-332. 
This is the nomenclature which I will use in this thesis.  
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Figure 1.3 Laminin structure 
A. Each laminin molecule is formed as an obligate heterotrimer, with an alpha, a beta 
and a gamma chain. These usually combine to form a cross-shaped molecule (left), 
although the truncated short arms of the alpha 3A and alpha 4 chains results in a T-
shaped structure (right). B. The trimers are then able to polymerise further to form a 
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Different isoforms have different distributions 
It has been shown that expression of different laminin chains varies between organs 
and at different stages of development (Yurchenco et al., 2004, Miner et al., 1997). 
These differences are mainly (although not exclusively) determined by variation in 
expression of α chains, with other chains (such as β1 and γ1) being ubiquitously 
expressed. This is perhaps reflective of the fact that laminin α chains display greater 
sequence divergence than the β and γ chains (Tryggvason, 1993). The main 
distribution of laminin isoforms is shown in table 1.1.  
As well as different tissue distributions, there are also different temporal patterns of 
laminin expression during development. During in vitro skin morphogenesis, there is 
differential expression of the laminin α chains. Laminin α1 is up-regulated during the 
early proliferative phase, whereas laminin α2 and α5 chains were expressed during 
the later differentiation phase (Fleischmajer et al., 2000). 
This led to speculation that individual isoforms may have unique functions in 
specific tissues (Vachon and Beaulieu, 1995, Turck et al., 2005, Nguyen and Senior, 
2006). The observation that laminin alpha chains have different tissue distributions is 
supported by evidence from mouse models that show different effects of knock-out 
of specific laminin alpha chains (Scheele et al., 2007). Loss of either laminin α1 or 
α5 results in a non-viable embryo. However, mutations in some of the other laminin 
chains lead to discrete pathologies in mice that survive until after birth, despite 
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Table 1.1 Laminin isoforms and their expression. 
Laminin isoform  Main site of expression (modified from Durbeej, 2010) 
111 Embryonic epithelium, some adult epithelium (kidney, liver, 
testis, ovary), brain blood vessels 
121  Placenta 
211 Muscle, heart, peripheral nerve, testis 
221 Muscle, heart, peripheral nerve, neuromuscular junction 
213 Placenta, testis 
212/222 Peripheral nerve 
3A11, 3A21 Epidermis, amnion 
3A32 Epidermis, placenta, mammary gland 
3A33 Testis 
3B32 Skin, uterus, lung 
411 Endothelium, smooth muscle, fat, peripheral nerve 
421 Endothelium, smooth muscle, neuromuscular junction 
423 Retina/central nervous system 
511 Developing/mature epithelium, endothelium, smooth muscle 
521 Mature epithelium, mature endothelium, smooth muscle, 
neuromuscular junction, glomerular basement membrane 
523 Retina/central nervous system 
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Laminin α1 deficiency results in the absence of Reichert’s membrane and death by 
E6.5 (Miner et al., 2004). Loss of α2 results in severe congenital muscular dystrophy 
and peripheral neuropathy (Miyagoe et al., 1997). Loss of α3 results in skin blistering 
and glomerular problems (Ryan et al., 1999). Loss of α4 causes abnormalities in 
blood vessels, neuromuscular junctions, the peripheral nervous system and heart 
(Patton et al., 2001, Thyboll et al., 2002, Wallquist et al., 2005, Wang et al., 2006). 
Loss of laminin α5 is lethal by E16.5, with defects in neural tube closure, digit 
septation and placentation (Miner et al., 1998). Loss of laminin α5 also results in 
defects in kidney development including failed vascularisation of the glomerulus 
(Miner and Li, 2000). 
It is clear that specific laminin isoforms provide crucial signals to cells in multiple 
developmental processes. However, as well as their role in embryonic development, 
laminins are also found in a range of adult stem cell niches. The alpha chain 
composition of laminins in this setting varies between tissues. 
The adult neural stem cell niche in the mouse subependymal zone is characterised by 
expression of laminin α2, α4 and α5 (Kazanis et al., 2010).  
Within the eye, there are adult stem cells located in the limbal epithelium. There are 
marked variations in laminin alpha chain expression. Laminin α3 is expressed 
throughout the ocular epithelium and α5 is restricted to both limbal and conjunctival 
epithelium. In contrast, the laminin α1 and α2 chains are only expressed in the limbal 
region (Schlotzer-Schrehardt et al., 2007). 
 
Different effects of laminin isoforms on cell behaviour in vitro 
Much of the original in vitro work on the effects of laminin on cell behaviour have 
used laminin purified from the Engelbreth-Holm-Swarm sarcoma, which is laminin-
111. There is increasing evidence that there are differences between laminin isoforms 
in their ability to influence cell function. Until relatively recently, this work has been 
limited by the difficulties in obtaining sufficient quantities of purified forms of many 
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laminin isoforms to perform functional assays. However, it has now become possible 
to compare the effects of different laminin trimers in vitro. 
As well as demonstrating changes in transcription during development, in vitro 
experiments have now also shown a direct effect of specific laminin isoforms on cell 
behaviour. In mouse embryonic stem (ES) cells cultured on different matrix 
components, laminin-511 supported self-renewal and retention of pluripotency 
markers such as OCT-4, SOX-2 and Nanog. In contrast, laminin-332 enabled 
proliferation but loss of pluripotency; laminin-111 caused rapid differentiation and 
laminin-411 did not support survival (Domogatskaya et al., 2008).  
Similarly, using a cell line derived from human colonic adenocarcinoma, laminin-
211, -332 and -511 supported proliferation, whereas laminin-111 promoted intestinal 
cell differentiation (Turck et al., 2005). 
 
Evidence for effects of specific laminin isoforms within the liver 
Many of the descriptive studies looking at matrix composition of the niche have used 
a pan-laminin antibody that recognises a shared epitope common to all of the 
isoforms. However, there is some limited data on specific laminin isoforms within 
the liver. 
Laminin alpha chains have been studied following partial hepatectomy, a situation 
where regeneration occurs via mature hepatocytes rather than progenitor cells. In this 
case, there was a transient increase in laminin alpha 1 chain within the sinusoids, 
peaking at 6 days after partial hepatectomy (Kikkawa et al., 2005). Laminin alpha 1 
was produced by stellate cells. In vitro studies showed that laminin-111 promoted 
spreading of both sinusoidal endothelial cells and stellate cells more than laminin-
411 suggesting a functional effect. 
Laminin alpha 5 is expressed in hepatocellular carcinomas (Kikkawa et al., 2008). 
HCC cells express the laminin-binding receptors α3β1 and α6β1 integrins, as well as 
Lutheran. HCC cells attach to laminin alpha 5 more avidly than healthy hepatocytes. 
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Finally, in embryonic development, it has been shown that α1 and α5 have different 
effects in vitro with regard to bile duct formation. Researchers used a cell line 
derived from hepatoblasts from mouse fetal liver (Tanimizu et al., 2004). HPPL cells 
form cysts with a central lumen, a process which is believed to parallel 
developmental bile duct morphogenesis. Exogenous laminin α1 was necessary for 
the initial formation of cysts but not for their maintenance. By this stage, the cells 
produced their own laminin α5. Interference with laminin α5 production using small 
interfering RNA (siRNA) inhibited lumen formation (Tanimizu et al., 2012). This 
suggests that laminin α1 and α5 have sequential roles in initiating and completing 
bile duct morphogenesis. 
There is a lack of data on the specific laminin isoforms associated with HPC-
mediated regeneration. 
 
1.4 Laminin receptors 
There are a number of mechanisms by which changes in matrix can influence cell 
behaviour. Changes in the matrix content may affect cells indirectly by changing 
local concentrations of growth factors and altering physical properties of the tissue 
such as stiffness. However, the most direct mechanism of action is the binding of 
individual matrix components to cell surface receptors, resulting in intracellular 
signal transduction.  
 
Integrins 
The main group of cell-surface receptors which interact with the ECM are the 
integrins (Hynes, 1992, Barczyk et al., 2010). These are involved in a wide range of 
cellular processes including attachment, movement, differentiation and death. The 
integrins are a family of heterodimeric transmembrane proteins, each composed of an 
α and a β subunit. 18 alpha and 8 beta chains have been described in mammals. Not 
all subunits can combine with every other, with some restricted to a single partner. 
At present, there are 24 recognised combinations. The integrins can be grouped 
together according to ligand-binding specificity (Humphries et al., 2006). The ligand-
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receptor relationship is often promiscuous: several integrins can recognise the same 
ECM ligand, and similarly each integrin may bind a range of ECM components. The 
largest subgroups of integrins are those sharing the β1 and αv subunits. Integrins that 
bind laminin include α3β1, α6β1, α6β4 and α7β1 (Kikkawa et al., 2000).   
Binding of integrins to matrix can initiate a number of intracellular signalling 
pathways, including focal adhesion kinase (FAK), integrin-linked kinase (ILK) and 
phosphoinositide-3 kinase (PI3K) (Giancotti and Ruoslahti, 1999). Integrins can also 
interact with growth factor receptors, ion channels and the actin cytoskeleton. The 
activation of such intracellular pathways by integrins is termed “outside-in” 
signalling. Each alpha-beta integrin combination has its own signalling properties. 
Different cell types have unique integrin profiles which will determine not only 
which ECM they can bind, but also the downstream signalling pathways that will be 
activated. Further control is made possible by the ability of cells to regulate the 
affinity of integrin binding in response to intracellular changes, so-called “inside-
out” signalling (Hynes, 2002). 
  
Beta-1 integrin 
Although there a variety of receptors capable of interacting with laminin, the beta-1 
subunit is found in the majority of laminin-binding integrins. In particular, the α6β1 
integrin has been shown to be highly expressed on a number of stem cells (Nagato et 
al., 2005, Tate et al., 2004). Inhibiting α6β1 integrin function with blocking 
antibodies disrupts the behaviour of neuronal progenitor cells in mice (Shen et al., 
2008). 
As with laminins, the use of transgenic mice to study the role of integrins in cell 
behaviour has been limited by the critical role played during embryogenesis. 
Constitutive deletion of β1 integrin leads to embryonic death, long before any effect 
in the regenerating liver can be adequately assessed (Fassler and Meyer, 1995). 
Similarly, deletion of the α6 integrin subunit leads to a severe detachment of the 
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epidermis and death shortly after birth, and α3-null mice die shortly after birth due to 
defective kidney and lung development (Bouvard et al., 2001). 
Mutations can be induced in adult Drosophila flies using a flippase recombinase. In 
the Drosophila ovary, mutations in either laminin A or its corresponding integrins 
resulted in a loss of follicular stem cell renewal and affects the development of their 
progeny (O'Reilly et al., 2008). However, Drosophila have significantly less 
variation in either their laminin chains or integrin subunits. Studies in mice (which 
have the same laminin isoforms and integrins as humans) have used Cre-mediated 
recombination to demonstrate the role of β1-integrin in a number of specific cell 
types (Jones et al., 2006, Benninger et al., 2006, Lei et al., 2008, Raghavan et al., 
2000).  
Conditional deletion of beta-1 integrin in the intestinal epithelium causes a profound 
increase in proliferation and inhibited differentiation (Jones et al., 2006). Hedgehog 
expression was markedly reduced in the integrin knockout mice and transfection of 
intestinal epithelial cells with beta-1 integrin stimulates Hedgehog expression, 
suggesting that loss of Hedgehog signalling may be a mediator of this effect. 
 
Integrin expression in the liver 
In normal liver, human hepatocytes express only α1β1 (collagen-binding), α5β1 
(fibronectin-binding) and α9β1 (tenascin-binding) integrins (Volpes et al., 1991, 
Palmer et al., 1993, Scoazec, 1996). Cholangiocytes, which are in contact with a 
laminin basement membrane, express α3β1 and α6β1 (both laminin-binding) 
integrins. In inflammatory conditions, however, there is increased expression of α3β1 
and α6β1 integrins in the liver (Quondamatteo et al., 2004). Furthermore, in patients 
with chronic hepatitis C, the degree of upregulation of α6β1 integrin was closely 
related to the deposition of perisinusoidal laminin (Nejjari et al., 2001). In the CDE 
diet mouse model, as oval cell numbers increased, there was increased expression of 
mRNA for the α6 integrin subunit (Van Hul et al., 2009).  
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Non-integrin laminin receptors 
In addition to integrins, there are a number of other cell surface receptors which can 
interact with laminin. Syndecans are transmembrane glycoproteins which interact 
with the extracellular matrix (Couchman, 2003) and may modulate integrin 
signalling (Streuli and Akhtar, 2009). Non-integrin laminin-binding receptors also 
include dystroglycan and Lutheran blood group glycoprotein/basal cell adhesion 
molecule (BCAM). α-dystroglycan has a high affinity for laminin α1 and α2, 
whereas Lutheran/BCAM binds only to laminin α5. 
 
Physical characteristics of matrix 
As well as signalling pathways linked to specific cell surface receptors, the physical 
characteristics of the matrix, such as stiffness, can regulate cell behaviour. Culturing 
a hepatocellular carcinoma cell line on a gel of increasing stiffness led to increased 
proliferation, regardless of the overlying matrix coating (Schrader et al., 2011). The 
extracellular matrix can also bind to soluble growth factors, regulating their 
distribution, activation and presentation to cells. Hepatocyte growth factor (HGF), 
one of the key mitogens for hepatocytes, binds to collagen (Schuppan et al., 1998). 
Collagen-bound HGF was still able to induce proliferation of cultured hepatocytes, 
suggesting that it retains its biological activity. Collagen also sequesters MMPs and 
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1.5 Cre-lox recombination 
The use of transgenic animal studies to understand the role of laminins in adult stem 
cell behaviour has been limited by the critical role played during early embryonic 
development. Knock-out mice have demonstrated the requirement for specific ECM 
components in early embryonic development (Tsang et al., 2010). A major advance 
in the study of gene function has been the development of transgenic mice that allow 
site-specific DNA recombination.  
Newly-emerging technologies such as flippase recombination enzyme (Flp) or cyclic 
recombinase (Cre) allow conditional gene deletion in a tissue-specific and/or time-
specific manner (Branda and Dymecki, 2004). Using these techniques, the effects of 
gene deletion can be studied after a period of normal development. 
Cyclic recombinase (Cre) is a bacteriophage-derived enzyme that catalyses site-
specific recombination of DNA. Cre acts at specific 34 base pair target sequences 
known as loxP sites. Where 2 loxP sites occur in a cis arrangement, Cre recombinase 
will mediate the deletion of the intervening segment, and can be used to inactivate a 
gene of interest. By deleting a segment within a STOP codon, Cre recombinase can 
be used to activate a gene. A gene that is flanked by loxP sites is said to be floxed. 
As neither Cre nor loxP sites occur naturally in mammalian systems, they need to be 
introduced into the mouse genome using transgenic technology. By targeting the 
gene for Cre recombinase to a specific non-critical integration site using a knock-in 
strategy, gene deletion can be controlled by specific promoters to target specific 
tissues or cell types.  
A further level of control can be added by the use of fusion proteins, in which Cre 
recombinase is given a ligand binding domain that regulates access to the nucleus. 
Cre-ERT is a construct which requires the presence of exogenous tamoxifen in order 
to induce recombination. 
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1.6 Summary 
Stem cells are frequently associated with a specialised extracellular matrix or niche 
which is believed to be important in regulating their behaviour. Progenitor cells in 
regenerating adult liver have been shown to be closely associated with laminins, 
although the pattern of laminin isoforms has not been fully characterised. Work in 
other organs has demonstrated a functional role for laminins in regulating stem cell 
behaviour, but has highlighted the importance of specific isoforms in this process. 
The relevance of individual laminin isoforms as a potential mechanism of regulating 
LPC behaviour has not been assessed. Understanding the mechanisms by which 
extracellular matrix regulates progenitor cell behaviour may allow therapeutic 
interventions to enhance intrinsic regeneration in chronic liver disease, as well as 




Introduction  34 
1.7 Hypothesis 
My central hypothesis is that interaction between specific laminin isoforms and cell-
surface laminin receptors is required for the regulation of liver progenitor cell 
behaviour. 
 
This hypothesis makes the following predictions: 
1. Alteration of the matrix composition or blocking of cell-surface receptors will 
affect HPC behaviour in vitro. 





1.8 Aims of the project 
1. To define the specific laminin alpha chains associated with the hepatic progenitor 
cell response in the mouse liver. 
2. To examine the functional effect of specific laminin alpha chains on the hepatic 
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Chapter 2: Methods and Materials 
 
2.1 Animal models 
Wild-type mice were supplied by Harlan (UK). Transgenic mice were bred in house. 
All animals were maintained in 12 hour light/dark cycles with free access to food and 
water. All procedures were performed in accordance with UK Home Office 




 mouse colony was kindly provided by Owen Sansom (Beatson 
Institute, Glasgow). Genotyping was performed on ear notches, following digestion 
overnight in 50 mM Tris pH 8.5 with 12 mM MgCl2 and 500 μg/mL proteinase K 
(Sigma) at 60°C. The primers are listed in table 2.1. The PCR product was run on a 
1.5% agarose gel containing gel red dye for 40 minutes at 70V, and viewed under a 
VersaDoc Imaging System. 
 
Table 2.1 Primer sequences for genotyping 
Gene Primer sequence 
Ah-Cre forward CCTGACTAGCATGGCGATAC 
Ah-Cre reverse ATTGCCCCTGTTTCACTATC 
Mdm2 forward TGTGGAGAAACAGTTACTTC 









 mice aged 12 - 16 weeks were given intraperitoneal injections 
of either 40mg/kg or 20mg/kg of β-naphthoflavone (Sigma Aldrich) dissolved in 
corn oil at a concentration of 10mg/ml. Mice were culled by exposure to rising 
concentration of carbon dioxide.  
 
DDC model 
In the initial descriptive work in chapter 3, I have used liver sections and frozen 
tissue generated previously by another member of the Forbes group, Dr Luke 
Boulter. In his original experiments, S129 S2 mice aged 6-8 weeks were given 0.1% 
w/w 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) in chow for 8, 12 or 18 days, 
and culled as above. This has been shown to cause a biliary injury via accumulation 
of porphyrins and results in marked HPC expansion. 
 




 R26R-EYFP mouse colony was kindly provided by Prof Guoqiang 
Gu (Vanderbilt University School of Medicine, Nashville) and was bred in-house. 
This mouse strain has the transgene Cre recombinase fused with a tamoxifen 
response element, under the control of the cytokeratin-19 promoter. This is combined 
with an enhanced yellow fluorescent protein (EYFP) reporter located in the ROSA26 
locus that is preceded by a flox-stop-flox sequence, so that EYFP is expressed only 
after activation of the Cre (Srinivas et al., 2001). Genotyping was performed on ear 
notches by Transnetyx (Cordova, United States). 
K19Cre Lama5flox 
The Lama5flox mouse colony was kindly provided by Prof Jeffrey Miner 
(Washington University, Saint Louis) and bred in-house. The generation of this allele 
has been described previously (Nguyen et al., 2005). This was crossed with the 






 mice for 
experimental use.  
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K19Cre-Itgb1flox 
The Itgb1flox mouse colony was purchased from the Jackson Laboratory (Bar 







 mice for experimental use.  
rdTomato reporter 
For cell isolation, the R26R-EYFP reporter was bred out and replaced with the 
brighter rdTomato reporter from the Ai14 strain (Jackson laboratory, Bar Harbor, 
Maine, USA). 
Tamoxifen induction 
1g of tamoxifen (Sigma) was dissolved in 5ml of ethanol and suspended in 10ml 
cremophor. The resulting suspension was diluted in 35ml sterile PBS to give a final 
concentration of 20 mg/ml. 6 week old mice were given 3 doses of 4mg tamoxifen 
(200 µl) via intraperitoneal injection over a period of 5 days. 
Transgenic diets 
For the choline-deficient, ethionine supplemented (CDE) diet, transgenic mice were 
fed a diet of choline-deficient chow (MP Biomedicals) with sweetened drinking 
water containing 0.15% w/v ethionine (Sigma Aldrich). This was commenced 14 
days after the first tamoxifen injection and animals were harvested after 21 days of 
diet. 
For the DDC diet, transgenic mice were fed a diet of 0.1% DDC with normal 
drinking water. This was commenced 21 days after the first tamoxifen injection and 
animals were harvested after 14 days of diet. 
Tissue harvest 
Blood was collected by cardiac puncture at the time of tissue harvest. Liver tissue 
was fixed in either 10% formalin solution or methacarn (60% methanol, 30% 
chloroform, 10% glacial acetic acid) overnight. Fixed tissue was transferred to 70% 
ethanol prior to paraffin embedding. In addition, tissue was snap-frozen on dry-ice 
and stored at -80°C for RNA extraction, and embedded in OCT embedding matrix 
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(CellPath) prior to immersion in a bath of isopentane surrounded by dry ice for 
frozen sections. 
2.3 Immunohistochemistry 
3 µm sections of paraffin-embedded tissue were dewaxed in xylene and rehydrated 
through decreasing concentrations of ethanol (100%, 90%, 80%, 65% and water). 
Where required, antigen retrieval was performed by either microwaving in either 
0.01M sodium citrate pH6, Tris-EDTA pH9 or treating with 125 µg/ml proteinase K 
in a waterbath at 37°C.  
For diaminobenzidine (DAB) staining, endogenous peroxidase activity was quenched 
by immersion in 1% hydrogen peroxide for 15 minutes prior to blocking with avidin 
and biotin. Non-specific binding was blocked by incubation with protein block 
(Spring Bioscience) for 30 minutes. Sections were incubated with primary antibody 
in Antibody Diluent Reagent Solution (Invitrogen), for either 1 hour at room 
temperature or overnight at 4°C. To confirm the specificity of staining, appropriate 
isotype controls were used for each primary antibody where available; where isotype 
controls were not available (eg. the laminin alpha 5 antibody provided by Prof 
Watts), a control was performed using no primary antibody instead. A list of all 
primary antibodies is given in table 2.2.  
Following washing, sections were incubated with a biotinylated secondary antibody 
for 30 minutes, followed by ABC reagent (Vector) for 30 minutes. Finally, sections 
were treated with DAB (Liquid DAB Substrate Chromogen System, DAKO) for 5 
minutes, prior to counterstaining with haematoxylin, dehydration through alcohols 
and xylene, and mounting in Pertex hard setting mounting medium. 
For immunofluorescence, sections were incubated with protein block prior to the 
primary antibody. Secondary antibodies were conjugated to Alexa Fluor 488 or 555 
(Invitrogen). Where further signal amplification was required or additional antigen 
retrieval was required for dual immunofluorescence, a Tyramide Signal 
Amplification kit was used (PerkinElmer). Slides were mounted using DAPI 
Fluoromount-G (Southern Biotech). 
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For frozen sections, 10 µm sections were air-dried and stored at -20°C prior to 
fixation in ice-cold methanol and acetone. 
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Antigen retrieval Dilution 





Mouse Sigma  
A5228 
Sodium citrate 1/2000 
Collagen I Goat SouthernBiotech 
1310-01 
Sodium citrate 1/400 
Collagen III Goat SouthernBiotech 
1330-01 
Sodium citrate 1/400 
F4/80 Rat Abcam  
ab6640 
Proteinase K 1/100 
GFP Chicken Abcam 
ab13970 
Tris-EDTA 1/500 
HNF4a Goat Santa-Cruz  
sc-6556 
Sodium citrate 1/100 
Integrin alpha 3 Rabbit Millipore 
AB1920 
Frozen 1/500 
Integrin alpha 6 Rat Millipore 
MAB 1378 
Frozen 1/100 
Integrin beta 1 Rat Millipore 
MAB1997 
Frozen 1/100 
Keratin 19 Rabbit Abcam Tris-EDTA 1/100 
 
Methods and Materials  41 
ab15463 
Ki67 Rabbit Novocastra Ki67p Tris-EDTA 1/500 
Laminin Rabbit Abcam 
ab11575 
Sodium citrate 1/25 
Laminin alpha 1 Rat Santa Cruz  
sc-65645 
Frozen 1/100 
Laminin alpha 2 Rat Axxora ALX-804-
190-C100 
Frozen 1/2000 
Laminin alpha 5 Rabbit CRUK-1186-018 Sodium citrate / 
frozen 
1/3500 
MIC1-1C3 Rat Novus 
NBP1-18961 
Frozen 1/100 
Osteopontin Goat R&D 
AF808 
Tris-EDTA 1/250 
Pancytokeratin Rabbit DAKO  
Z0622 
Sodium citrate 1/200 
P53 Mouse Abcam 
ab26 
Sodium citrate 1/500 
Sox9 Rabbit Santa Cruz     
sc20095 
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Assessment of tissue sections 
Stained slides were blinded and randomised prior to photographing for 
quantification. For panCK quantification, a minimum of 20 serial, non-overlapping 
fields were photographed at x200 magnification. For YFP quantification, 20 
consecutive portal tracts were photographed at x400 magnification. 
 
2.4 Quantitative PCR analysis 
Total RNA was extracted from snap-frozen liver tissue using TriReagent 
(Amersham). Following homogenisation, chloroform was added in a ratio of 1 part 
chloroform: 5 parts Trizol, mixed well and centrifuged at 12000 rpm for 15 minutes 
at 4°C. The aqueous layer was then mixed with an equal volume of 70% ethanol in 
RNase-free water, prior to use of RNeasy Mini Kit (Qiagen, UK) elution columns. 
The resulting RNA concentration was measured using a NanoDrop (ThermoFisher). 
RNA extraction from cells was performed using RLT lysis buffer (Qiagen) in place 
of TriReagent. 
Reverse transcription was performed using the Qiagen kit according to 
manufacturer’s instructions. Pre-designed validated primer sets were purchased from 
Qiagen (listed in table 2.3). 
qPCR reaction mixtures were prepared using SYBR-Green. Each reaction consisted 
of 5 µl of cDNA, 6.25 µl of SYBR mastermix and 1.25 µl of primers. Samples were 
prepared in 384 well plates and run using a LightCycler480. Data was analysed using 
the LightCycler480 software. All reactions were performed in triplicate. Gene 
expression was internally controlled by measuring expression of the housekeeping 
gene peptidylprolyl isomerase A (PPIA) in the same sample. 
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Table 2.3 qPCR primers used 
Gene Code 
Albumin QT00115570 
E-cadherin QT00121163   
EpCAM QT00248276   
Integrin alpha 3 QT00125678 
Integrin alpha 6 QT00144354 
Integrin alpha 7 QT00136990 
Integrin beta 1 QT00155855 
Integrin beta 4 QT01065729    
Keratin-19 QT00156667  
 
Laminin alpha 1 QT00163394 
Laminin alpha 2 QT00155589 
Laminin alpha 3 QT01889104 
Laminin alpha 4 QT00149583 
Laminin alpha 5 QT01750637 
PPIA QT00247709   
 
2.5 Cell culture 
The Bmol cell line was kindly provided by George Yeoh, University of Western 
Australia. The derivation and characterisation of these cells is discussed in more 
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detail in chapter 4. Bmol cells were cultured in William’s E + GlutaMAX-1 medium 
(Gibco) supplemented with 100 units/ml penicillin and 100 µg/ml streptomycin 
(PAA) and 2% fetal calf serum, unless stated otherwise. Cells were cultured in a 
humidified atmosphere with 5% carbon dioxide at 37°C. 
 
2.6 Matrix coating of plates 
Recombinant human laminin-111, -211, -411 and -511 (Biolamina) were diluted in 
sterile phosphate buffered saline (PBS) to a concentration of 20 µg/ml. Wells were 
coated for 1 hour at 37°C, or overnight at 4°C, and then washed with PBS. 
 
2.7 Attachment assay 
Cells were trypsinised and suspended at 1x10
5
 cells/ml. A 96-well plate was coated 
with matrices as above, and incubated with 3% bovine serum albumin (BSA) to 
block non-specific binding. 100 µl of cell suspension was added to each well and 
incubated for 30 minutes at 37°C. The wells were then washed twice with PBS to 
remove any unattached or loosely attached cells. The remaining cells were fixed with 
5% glutaraldehyde, stained with crystal violet, and solubilised in 10% acetic acid. A 
spectrophotometer was used to determine absorbance at 570nm. Blank wells without 
cells were used as controls. Each experiment was performed using a minimum of 5 
wells per condition, and was repeated at least once.  
 
2.8 Spreading assay 
Cells were trypsinised and suspended at 2 x10
4
 cells/ml. A 96-well plate was coated 
with matrices and blocked with BSA. 100 µl of cell suspension was added to each 
well and incubated for 60 minutes at 37°C. The cells were fixed directly by the 
addition of 25% glutaraldehyde to the wells without any washing. Cells were 
washed, stained with crystal violet and photographed using a x40 objective lens. 
Image analysis software (ImageJ) was used to measure the area of 100 cells per well. 
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2.9 Migration assay 
Cells were trypsinised and incubated with 5 µg/ml mitomycin C for 2 hours, and re-
suspended at 5 x10
5
 cells/ml. 100 µl of cell suspension was added per well of an Oris 
migration plate, and incubated overnight to allow confluent cell attachment. The 
stoppers were removed to create a standardised central defect. Control wells were 
fixed immediately with 5% glutaraldehyde. The remaining wells were fixed at 24 
hours. Cells were stained with crystal violet and photographed. Quantification of cell 
migration was performed using ImageJ. Integrin-blocking antibodies (MCA699X2 
and MCA2298EC) were used at 25 µg/ml. 
 
2.10 MTT assay 
Cells were trypsinised and suspended at 5x10
4
 cells/ml. 100 µl of cell suspension 
was added per well of a 96-well plate. Cells were incubated at 37°C for 48 hours. 20 
µl of MTT solution was added per well to the medium. After 3 hours, the medium 
was aspirated and 100 µl of DMSO was added and the plate was placed on an orbital 
shaker at 200rpm for 5 minutes. A spectrophotometer was used to determine 
absorbance at 570nm.     
 
2.11 EdU assay 
Cells were cultured in 48 well plates at 1 x10
5
 cells/ml. After 48 hours on matrix, 
100 µl of 20 µM EdU was added to each well and cells were incubated for 3 hours. 
Cells were fixed with 4% formaldehyde prior to washing with 3% BSA in PBS and 
permeabilising with 0.1% TritonX in PBS. The Click-It reaction was used as per 
manufacturer’s instructions and photographed for quantification. 
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2.12 siRNA transfection 
Small interfering RNA (siRNA) against laminin alpha 5 was obtained from Qiagen 
(FlexiTube GeneSolution, Cat No GS16776). Oligonucleotides were suspended in 
100 µl of RNAse-free water. Cells were suspended at 1 x 10
5
 cells/ml and plated. 
Cells were transfected using HiPerFect reagent (Qiagen) as per manufacturer’s 
instructions. A mastermix of siRNA was prepared in serum-free medium with 37.5ng 
of siRNA and HiPerFect reagent. This was vortexed and left for 10 minutes to form 
complexes before adding dropwise to the cells. 
Efficiency of transfection was assessed using an ELISA kit against mouse laminin 
alpha 5 (AMS Biotechnology). 
 
2.13 Isolation of cells 
Livers were perfused in situ with 10ml of Gibco Liver Perfusion medium, followed 
by 20ml of Gibco Liver Digestion medium. Following this, the livers were excised, 
chopped and homogenised using a gentleMACS Dissociator (Miltenyi Biotec). The 
resulting homogenate was incubated for 30 minutes at 37°C, before being passed 
through a 70 µm filter. This was spun at 50G for 5 minutes to remove hepatocytes, 
and the supernatant containing the non-parenchymal fraction was then pelleted at 
300G for 5 minutes. 
HPCs 
The non-parenchymal fraction was resuspended and spun over a discontinuous 
Percoll gradient (Sigma). Cells isolated from the 20%/50% boundary were washed 
and plated in HPC selective medium (Okabe et al., 2009): Williams’ Medium E 
(Gibco) containing 10% FCS, 17.6 mM NaHCO3, 20mM HEPES pH 7.5, 10 mM 
nicotinamide, 1 mM sodium pyruvate, 1x insulin transferrin selenium (ITS) solution 
(Gibco), 100 nM dexamethasone, 0.2 mM ascorbic acid, 14 mM glucose, 10 ng/mL 
IL-6 (Peprotech), 10 ng/mL HGF (Peprotech), 10 ng/mL EGF (Sigma-Aldrich). Cells 
were washed after 24 hours to remove unattached or dead cells and cultured for 14 
days. 
 
Methods and Materials  47 
Hepatic stellate cells 
The non-parenchymal fraction was resuspended and spun over a discontinuous 
OptiPrep gradient (Sigma). Cells isolated from the 40%/60% boundary were plated 
in DMEM containing 20% FCS, L-glutamine and sodium pyruvate for a minimum of 
3 passages until a typical stellate morphology was observed. 
Recombined cells for gene array 
The non-parenchymal fraction was incubated with 1/100 dilution of anti-mouse 
CD45-PE conjugated antibody (eBioscience, 12-0451-82) and 7-amino-actinomycin 
D (7-AAD) (eBioscience, 00-6993-50) for 10 minutes prior to washing and sorting 
using a BD FACS Aria II. 
 
2.14 Statistical analysis 
Statistical analysis was performed using GraphPad Prism 5 (GraphPad Software). 
Parametric data were analysed by Student’s t-test or one-way ANOVA, whilst non-
parametric data were analysed by Mann-Whitney or Kruskal-Wallis tests. 
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Chapter 3: Characterisation of laminin isoforms 
in the adult hepatic progenitor cell response 
 
3.1 Introduction 
Although an association between hepatic progenitor cells and extracellular laminins 
has been demonstrated previously by several groups (Lorenzini et al., 2010, Van Hul 
et al., 2009), the subunit composition of the laminins in this setting has never been 
described. As the various laminin isoforms can have different effects on cell 
behaviour, I sought to define the changes in specific laminin chains during the 
progenitor cell response.  
Liver progenitor cells are bipotential and occur in response to both hepatocytic and 
biliary injury. I have therefore chosen to examine two models of progenitor-mediated 
injury to reflect these two different regenerative responses. The AhCre-Mdm2
flox 
mouse (which I will hereafter refer to as the ‘Mdm2 mouse’ for brevity) is a recently 
described transgenic model that induces hepatocyte-specific injury and induces a 
robust progenitor cell response (Lu et al, under review). In contrast, DDC is an 
orally-administered toxin that produces a predominantly biliary injury accompanied 
by HPCs. 
As the Mdm2 mouse is a novel model that was still being developed by our group, I 
first set out to optimise the induction dosage and to characterise the time-course of 
progenitor cell expansion. 
Using both models, I aimed to characterise the laminin alpha chain expression using 
a combination of qPCR and immunohistochemistry. I then compared stellate cells 
and HPCs in culture to identify the cell type responsible for the synthesis of the 
predominant isoforms. I also aimed to examine the expression of laminin-binding 
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3.2 Results 
Refinement of a model of hepatocellular injury via conditional deletion 
of Mdm2 
In the transgenic AhCre mouse strain, Cre recombinase is conditionally expressed 
under the regulation of a rat cytochrome p450 (Cyp1a1) promoter element. This is 
up-regulated in many of the epithelia of the gastrointestinal tract, including 
hepatocytes, in response to the xenobiotic beta-naphthoflavone (Ireland et al., 2004). 
This strain was crossed with a floxed Mdm2 (murine double minute 2) gene (Grier et 
al., 2002), resulting in an inducible loss of MDM2 within hepatocytes and other 
epithelia. This is shown diagrammatically in figure 3.1A. A representative 
genotyping gel in figure 3.1B shows the amplification products of the AhCre and 
both wild-type and floxed Mdm2 alleles. In the following experiments, all mice used 
had a single copy of the AhCre transgene and were homozygous for the floxed 
Mdm2 gene. 
MDM2 is a negative regulator of the tumour suppressor gene p53, and loss of 
MDM2 results in rapid up-regulation of p53. High p53 levels result in cell cycle 
arrest and can initiate apoptosis.  
The initial characterisation of this transgenic model was performed by Thomas Bird, 
who demonstrated that a single dose of 80 mg/kg of beta-naphthoflavone 
administered intraperitoneally (i.p.) induced a florid HPC response. However, this 
model was associated with an unacceptably high mortality. I therefore set out to 
modify the model, in order to develop a robust model of progenitor-mediated 
hepatocellular regeneration that remained within moderate severity limits, in which 
to study the changes in extracellular matrix. 
A single dose of 40 mg/kg of beta-naphthoflavone still resulted in significant 
mortality, with five out of six mice dying or requiring euthanasia by day 7. A further 
dose reduction to 20 mg/kg was much better tolerated, with the majority of animals 
surviving to 14 days (figure 3.1C). The 20mg/kg dose was associated with less 
weight loss at days 5 and 6 after the beta-naphthoflavone injection, and the mice 
started to gain weight again by day 7 (figure 3.1D). By day 6 after induction, mice 
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had fallen to 85.5% of their starting weight with the lower dose, compared with 
78.0% in the higher dose group. 
Having established tolerability, I wanted to assess whether the lower 20 mg/kg dose 
would still induce adequate liver injury to be a useful model for studying progenitor 
cells.  
As described earlier, genetic recombination will result in loss of MDM2 and 
subsequent up-regulation of p53. Using p53 immunostaining, Thomas Bird had 
shown that the 80 mg/kg dose resulted in recombination in more than 99% of 
hepatocytes. I have shown that the 20 mg/kg dose still resulted in high levels of p53-
positive hepatocytes, with approximately 80% of hepatocytes showing nuclear 
staining 3 days after induction (figure 3.1E).   
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Figure 3.1 – Dose-finding study for the AhCre-Mdm2
flox
 model 
A. Activation of the AhCre transgene by beta-naphthoflavone results in deletion of 
the floxed Mdm2 gene in hepatocytes and other gut epithelial tissues. B. A 
representative genotyping gel shows the amplification products of the AhCre 
transgene (top band, 1 kbp) and both wild-type (342 bp) and floxed (474 bp) Mdm2 
alleles. Lane 1 shows a homozygous flox/flox mouse (experimental animal) and lane 
2 shows a heterozygote flox/wild-type (for comparison). C. Kaplan-Meier survival 
curves for high dose (40mg/kg) and low dose (20mg/kg) beta-napthoflavone show 
significantly lower mortality with the lower dose. Log-rank (Mantel-Cox) test 
p<0.0001. D. Weight loss following induction was initially similar between the two 
groups but there appeared to be a trend towards greater weight loss with the higher 
dose at later time points. E. p53 staining is not seen in an uninduced mouse liver but 
is seen in the majority of hepatocytes at day 3 after induction with 20 mg/kg, 
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Characterisation of the HPC response in the AhCre-Mdm2 model 
Having demonstrated an improved tolerability at the expense of a modest reduction 
in recombination, I then wanted to see whether this still resulted in liver injury and 
expansion of the HPCs. I characterised the response to a 20 mg/kg dose of beta-
naphthoflavone at days 0, 3, 5, 7, 10 and 14 (figure 3.2A). I measured serum alanine 
transaminase (ALT) as a measure of hepatocellular injury. Even at the reduced dose, 
there is still a rapid and statistically significant rise in ALT (figure 3.2B). The 
median ALT increases from 37 IU/L at day 0 to 508 IU/L at day 7. 
To identify HPCs, I stained liver sections for pancytokeratin, a marker of both 
mature bile ducts and HPCs (figure 3.2C). In the uninjured liver, pancytokeratin 
staining is mostly limited to the portal tracts and represents bile ducts with very few 
HPCs. Following induction with beta-naphthoflavone, there is a steady increase in 
periportal staining, with cords of cells extending into the liver parenchmya. These 
cells are morphologically typical for HPCs. 
For quantification, I counted pancytokeratin-positive cells but excluded those 
obviously associated with well-defined lumens which represent interlobular bile 
ducts. There is a significant increase in panCK-positive cells (figure 3.2D), rising 
from 10.3 cells per field at day 0 to a peak of 53.8 cells per field at day 10. 
Because of a lack of consensus for HPC markers, I also stained the livers from the 
day 10 time point for the alternative HPC markers keratin-19 (figure 3.2E) and 
osteopontin (figure 3.2F). Both markers show the same pattern of periportal cells 
extending into the parenchyma, further supporting the claim that these are HPCs. 
This model produces a rapid and robust expansion of HPCs following a single 
defined hepatocellular injury that is greater than that seen with the CDE diet. This 
also offers the unique opportunity to look at the timecourse of HPC expansion and 
differentiation in a way that cannot be achieved with the CDE or DDC dietary 
models, as these will have ongoing injury over a prolonged period with ongoing 
generation of progenitors. 
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Figure 3.2 – Characterisation of the HPC response in the AhCre-Mdm2
flox
 model 
A. Schematic of experimental design. A single 20 mg/kg dose of beta-
naphthoflavone was given intraperitoneally to adult AhCre-Mdm2flox mice, and 
tissues were harvested at days 0, 3, 5, 7, 10 and 14. B. There was a significant 
elevation of serum alanine transaminase (ALT) levels after induction, with a peak at 
7 days. Bars represent median and interquartile range; n=3-6 animals per group, 
Kruskal-Wallis test p0.007, Dunnett’s multiple comparison test for each time point 
vs day 0 *p<0.05, **p<0.01. C. Pancytokeratin (panCK) staining in the normal liver 
is found predominantly in the bile ducts with very few HPCs seen. Following 
induction, there is a progressive increase in panCK-positive cells in the periportal 
areas which then extend into the lobule. D. Quantification of panCK-positive cells 
shows a significant peak at day 10 after induction. Bars represent median and 
interquartile range; n=4-6 animals per timepoint, Kruskal-Wallis test p0.02, 
Dunnett’s multiple comparison test for individual time points compared to day 0. E-
F. Staining for keratin-19 and osteopontin shows the same pattern of periportal HPC 
expansion at day 10. Original magnification x400. Scale bars represent 50 µm. 
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Characterisation of the HPC niche in the Mdm2 model 
HPCs occur in association with a stereotypical niche (Lorenzini et al., 2010, Van Hul 
et al., 2009). This consists of other cell types (hepatic stellate cells and macrophages) 
and extracellular matrix (collagen and laminin). As the Mdm2 model is novel, I 
wanted to confirm that the niche constituents seen in other HPC models are present 
here too. 
Using immunohistochemistry, I compared the livers from the point of maximal HPC 
numbers (day 10 post-induction) with uninduced livers. Alpha smooth muscle actin 
staining shows the presence of very few activated myofibroblasts in the uninduced 
liver (figure 3.3A), contrasted with a marked increase in myofibroblasts in the 
periportal region at day 10 following induction (figure 3.3B). F4/80 staining shows 
an even distribution of macrophages throughout the lobule in the uninduced liver 
(figure 3.3C), with periportal expansion of macrophage numbers at day 10 (figure 
3.3D). 
Collagen I staining in the uninduced liver (figure 3.3E) is focussed mainly around 
blood vessels and bile ducts, with minimal sinusoidal staining. At day 10 following 
induction (figure 3.3F) there is an increase in periportal staining, extending into the 
lobule. Collagen III staining is very restricted in uninduced liver with minimal blood 
vessel staining only (figure 3.3G) but is also expanded in the periportal region at day 
10 (figure 3.3H).   
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Figure 3.3 Characterisation of the HPC niche in the Mdm2 model 
Immunohistochemistry of liver sections from uninduced AhCre-Mdm2
flox
 mice 
(A,C,E,G) and at 10 days after induction with 20mg/kg beta-naphthoflavone 
(B,D,F,H). HPC expansion is accompanied by an increase in both activated 
myofibroblasts and macrophages, as demonstrated by alpha smooth muscle actin (A-
B) and F4/80 (C-D) staining respectively. There is also an increase in both collagen I 
(E-F) and collagen III (G-H) staining. Original magnification x200. Scale bars 
represent 100 µm. 
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Biliary injury with DDC triggers a hepatic progenitor cell response 
Having established a model of HPC expansion in the setting of hepatocyte injury, I 
also wanted to examine a model of biliary injury. A well-established paradigm in the 
literature is the DDC diet. Using archival tissue kindly provided by Luke Boulter, I 
compared adult mice fed normal chow with those fed 8, 12 or 18 days of DDC-
containing diet (figure 3.4A). Using pancytokeratin staining, I was able to 
demonstrate HPC expansion with increasing duration of diet (figure 3.4B). In the 
AhCre-Mdm2
flox
 model, the HPCs appeared as infiltrating cords extending into the 
liver parenchyma. In contrast, in the DDC model, the HPCs retain a ductular 
appearance and are mostly in contact with a lumen. 
As before, these cells also stain for keratin-19 (figure 3.4C) and osteopontin (figure 
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Figure 3.4 – HPC expansion in DDC model 
A. Schematic of experimental design. S129 mice aged 6-8 weeks were fed diet 
containing 0.1% DDC and culled after 0, 8, 12 or 18 days. B. Immunohistochemistry 
for pancytokeratin (panCK) shows a progressive increase in periportal panCK-
positive cells with DDC-containing diet. Original magnification x400. Scale bars 
represent 50 µm. These periportal cells also stain for keratin-19 (C) and osteopontin 
(D), consistent with HPCs. Original magnification x600. Scale bars represent 50 µm.  
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Both models of HPC expansion are associated with increased laminin 
Having demonstrated HPC expansion in both of my models, I then sought to confirm 
the association with extracellular laminin that has been described elsewhere. Using a 
pan-laminin antibody that binds all isoforms, I performed immunohistochemistry on 
liver sections from both models. In the normal liver, laminin expression is expected 
to be mostly restricted to the basement membrane around bile ducts and blood 
vessels with very little sinusoidal laminin. This is indeed the pattern seen in both the 
uninduced Mdm2 mice (figure 3.5A,C) and S129 mice fed normal chow (figure 
3.5E). Following induction with beta-naphthoflavone, the Mdm2 mice show marked 
expansion of laminin in the periportal region (figure 3.5B,D). This appears to form a 
discrete basement membrane-like structure around the HPCs. A similar increase in 
laminin staining is seen in the S129 mice exposed to DDC-containing diet (figure 
3.5F). 
In order to better demonstrate the association between HPCs and laminin, I 
performed dual colour immunofluorescence. In figure 3.5G, the HPCs are shown in 
red and laminin is shown in green. It can be seen that laminin forms a basement 
membrane around the bile ducts with projections extending into the parenchyma 
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Figure 3.5 –HPCs are associated with laminin in both models 
A-F. Immunohistochemistry for laminin. Laminin staining in the uninduced Mdm2 
mouse liver (A x200 magnification, C x400) is restricted to the basement membrane 
of bile ducts and blood vessels, with no sinusoidal staining. 10 days after induction 
with 20 mg/kg of beta-naphthoflavone (B x200, D x400), there is marked expansion 
of laminin staining in the periportal region. E-F. A similar pattern is seen when 
comparing S129 mice fed normal chow (E) and after 18 days of DDC-containing diet 
(F). G. Dual colour immunofluorescence shows co-localisation of laminin (green) 
and panCK (red), with laminin closely surrounding the HPCs in the DDC model. 
Original magnification x400. Scale bars represent 50 µm. 
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Laminin alpha 5 chain is upregulated during the HPC response 
Having established an increase in laminins in both models of HPC expansion, I then 
wanted to identify whether specific laminin isoforms were predominant. 
Extracellular matrix proteins can be regulated by both the rate of synthesis and the 
rate of degradation. However, given the low levels of laminin expression in the 
normal liver, I felt it was most likely that the change is due to an increase in 
synthesis and I therefore started by looking at laminin gene transcription. The alpha 
chains are believed to be the main determinant of cell surface receptor binding. I 
therefore performed qPCR on whole liver tissue at multiple time points during the 
HPC response, looking for mRNA for each of the 5 alpha chains. 
The changes in alpha chain transcription in the Mdm2 model are shown in figure 3.6. 
I firstly looked at the multiple time points after low dose (20 mg/kg) beta-
naphthoflavone (figure 3.6A-E). Significant increases were seen in laminin alpha 1 
(Figure 3.6A, peak increase of 3.3-fold at day 7) and alpha 5 (Figure 3.6E, peak 
increase of 13.6-fold at day 7). In contrast, alpha 3 was significantly reduced (Figure 
3.6C, peak reduction of 9.4-fold at day 10). There was no significant change from 
baseline in either laminin alpha 2 or alpha 4.  
I also looked at the two time points available from the higher dose (40 mg/kg) of 
beta-naphthoflavone (figure 3.6F). This showed significant increases in laminin 
alpha 2 and alpha 5, to 11.5 and 16.5 times their values in the uninjured liver 
respectively. 
The changes in alpha chain transcription in the DDC model are shown in figure 3.7. 
In this case, significant increases were seen in laminin alpha 2 (Figure 3.7B, 4.7-fold 
increase at day 12) and alpha 5 (figure 3.7E, 4.2-fold increase at day 12). There was 
a significant reduction in alpha 3 (figure 3.7C, 17.1-fold reduction at day 18). There 
was no significant change in laminin alpha 1 or alpha 4.  
The consistent change across both models was therefore an increase in laminin alpha 
5 (and possibly alpha 2) and a reduction in alpha 3 gene transcription. 
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Figure 3.6 – Laminin alpha chain qPCR in Mdm2 model  
A-E. AhCre+ Mdm2flox/flox mice aged 12-16 weeks were given a single dose of 20 
mg/kg beta-napthoflavone by i.p. injection. Laminin alpha chains were assessed by 
qPCR of whole liver tissue. Values were normalised to the housekeeping gene PPIA 
and expressed relative to the expression at day 0. Data are shown as median +/- 
interquartile range, and were analysed by a Kruskal-Wallis test. Where significant 
differences were found, Dunnett’s multiple comparison test was used to compare 
each time-point with day 0. * p<0.05, ** p<0.01. n=3-6 animals per group. A. Alpha 
1, Kruskal-Wallis, p 0.0018. B. Alpha 2, Kruskal-Wallis p NS. C. Alpha 3, Kruskal-
Wallis p 0.0048. D. Alpha 4, Kruskal-Wallis p NS. E. Alpha 5, Kruskal-Wallis p 
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Figure 3.7 – Laminin alpha chain qPCR in DDC model  
A-E. S129 mice aged 6-8 weeks were given diet containing 0.1% DDC. Laminin 
alpha chains were assessed by qPCR of whole liver tissue. Data are shown as median 
+/- interquartile range, and were analysed by a Kruskal-Wallis test. n=8 animals per 
group. A. Alpha 1, Kruskal-Wallis, p NS. B. Alpha 2, Kruskal-Wallis p 0.0048. C. 
Alpha 3, Kruskal-Wallis p 0.0004. D. Alpha 4, Kruskal-Wallis p NS. E. Alpha 5, 
Kruskal-Wallis p 0.0005. Where significant differences were found, Dunn’s multiple 
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Laminin alpha 5 chain closely associates with the HPCs 
Having shown differential gene expression for the laminin alpha chains during the 
HPC response, I wanted to confirm these changes at a protein level. I therefore 
performed immunohistochemistry using antibodies specific for laminin alpha 1, 
alpha 2 and alpha 5 chains in both the Mdm2 (figure 3.8A) and DDC (figure 3.8B) 
models. It can be seen that there is a slight increase in laminin alpha 1 and 2 chains, 
but the most striking increases are seen in laminin alpha 5. 
Dual immunofluorescence was used to confirm the colocalisation of laminin alpha 5 
with the HPCs (figure 3.8C). As the previously described markers (panCK, K19, 
osteopontin) are all stained for using antibodies raised in the same species as the 
laminin alpha 5 antibody (rabbit), I used an alternative HPC marker called A6 which 
is raised in a different species (rat) to avoid any cross-reactivity. This marker is well-
described in the DDC model (Preisegger et al., 1999). It can be seen that the HPCs 
are closely associated with the laminin alpha 5. 
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Figure 3.8 – Lama5 co-localises with HPCs 
A. Immunofluorescence for laminin alpha 1, 2 and 5 on frozen sections from Mdm2 
model. Panels on the left show the control livers and those on the right show 
regenerating livers, at day 10 after induction with beta-naphthoflavone. Although 
there are slight increases in alpha 1 and alpha 2 chains, the most striking change is an 
increase in laminin alpha 5 deposition in the periportal region. Original 
magnification x200. Scale bars represent 50 micrometers. B. Immunofluorescence 
for the same laminin chains in the DDC model, after 12 days of diet shows a similar 
pattern of changes. Original magnification x200. C. Confocal microscopy showing 
colocalisation of laminin alpha 5 with the hepatic progenitor cell marker A6. Scale 
bar represents 100 micrometres.  
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Laminin alpha 5 is seen in human liver disease 
In order to confirm the relevance of these findings in mouse models to human 
disease, human liver tissue was obtained from the NHS Lothian Tissue Bank. 
Sections were obtained from explanted livers of patients undergoing liver 
transplantation for cirrhosis secondary to alcoholic liver disease, hepatitis C and 
primary sclerosing cholangitis. Sections were stained for pancytokeratin to 
demonstrate the presence of a ductular reaction (figure 3.8 A,C and E). Sections from 
the same livers were also stained for laminin alpha 5 (figure 3.8 B, D, F and G). 
Laminin alpha 5 expression is seen in each of the livers with a predominantly 
ductular distribution, suggesting its association with HPCs.  
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Figure 3.9 – Laminin alpha 5 is seen in human liver disease with ductular reactions 
Human liver sections from patients with alcoholic liver disease (A-B), hepatitis C 
(C-D), primary sclerosing cholangitis (E-F) and non-alcoholic fatty liver disease 
(G). Pancytokeratin staining (A,C,E) confirms the presence of ductular reactions in 
all livers. Staining for laminin alpha 5 (B,D,F,G) shows the same ductular pattern of 
staining. A negative control performed without primary antibody did not show any 
staining (H). Original magnification x400 for all images, scale bar represents 50 µm. 
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HPCs synthesise laminin alpha 5 
Having confirmed increased expression of laminin alpha 5 during regeneration, I 
wanted to identify the cellular source of the matrix. Hepatic stellate cells are the main 
matrix-producing cells in the liver, and are the predominant source of collagen 
during liver injury. Given the close association between HPCs and stellate cells, they 
would seem a likely candidate for the source of the laminin. However, as fetal 
hepatoblasts synthesise laminin during liver development, it is also possible that 
HPCs produce their own laminin niche.  
In order to address this question, I isolated both stellate cells and HPCs from the 
Mdm2 mouse model using density centrifugation and selective culture conditions 
(figure 3.10A). I then compared their transcription patterns for the different laminin 
alpha chains using qPCR. Figure 3.10B shows that laminin alpha 1 mRNA 
expression is 10-fold higher in stellate cells than progenitors, and alpha 2 expression 
is 21-fold higher in stellate cells. Both of these just fail to reach statistical 
significance with p values of 0.06. Conversely, laminin alpha 5 is the only chain 
which appears to be produced predominantly by progenitor cells rather than stellate 
cells, with 2.5-fold higher mRNA levels (p 0.11). Although none of these changes 
reached statistical significance, there were only 3-4 samples per group. Furthermore, 
the cell populations were enriched for stellate cells or HPCs through selective culture 
conditions but were not exclusive populations. There is likely to have been 
contamination from other cell types that will tend to reduce any differences. 
In order to confirm this result, I therefore also examined data that I extracted from a 
published gene array (Dorrell et al., 2011). The data are accessible at the NCBI GEO 
database (Edgar et al., 2002), accession number GSE29121. In this study, adult 
hepatic progenitor cells were isolated from DDC-treated mice using flow-assisted 
cell sorting for the cell surface markers CD133 and MIC1-1C3. A progenitor-
enriched population (CD133+, MIC-1C3+) was compared with the progenitor-
depleted (CD133-, MIC1-1C3-) non-parenchymal cells. Gene expression profiling 
was perfomed using Agilent Whole Mouse Genome Arrays. As shown in figure 
3.10C, the progenitor cells expressed significantly higher levels of the laminin alpha 
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5 chain (13.8-fold higher, p<0.05), whereas the progenitor-depleted cells expressed 
higher levels of laminin alpha 1 and 2. 
These data suggest that laminin alpha 5 is being synthesised predominantly by the 
progenitor cells themselves, in contrast to other laminin alpha chains which are being 
produced mainly by stellate cells.  
This is in keeping with the situation in intestinal development, where it has been 
shown that laminin alpha 2 comes from mesenchymal cells whereas laminin alpha 5 
comes from epithelial cells (Lefebvre et al., 1999). 
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Figure 3.10 – Cellular source of laminin alpha 5 
A. Livers from Mdm2 mice 7 days after induction were digested and purified using 
two protocols of density centrifugation followed by selective culture conditions to 
enrich for stellate cells and progenitor cells respectively. B. qPCR for laminin alpha 
chain gene expression from stellate cells and hepatic progenitor cells. Gene 
expression is normalised to the house-keeping gene PPIA. n=4 samples for 
progenitor cells, n=3 samples for stellate cells. No differences reached statistical 
significance by Mann-Whitney test but there was a trend towards higher laminin 
alpha 5 expression by the progenitor cells rather than stellate cells. C. Analysis of 
gene microarray data extracted from the GEO database from an original experiment 
by Dorrell et al (2011). Progenitor cells were isolated from the DDC model using 
flow-activated cell sorting for CD133+ and MIC1-1C3+  cells, and compared with 
progenitor-depleted (CD133- MIC1-1C3-) non-parenchymal cells. n=4 samples for 
both groups. This showed laminin alpha 1 and 2 expression was greater in the 
progenitor-depleted population and alpha 5 expression was greater in the progenitor-
enriched population. Expression of each gene was compared using a Mann-Whitney 
test. *p<0.05.  
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Laminin-binding integrins are upregulated during HPC expansion 
Laminin can interact with a range of cell surface receptors to influence cell 
behaviour. The best described of these are the integrin family. These are 
heterodimers, consisting of an alpha and beta subunit. The integrins that are most 
widely accepted as laminin receptors are α3β1, α6β1, α7β1 and α6β4. I therefore 
looked at the transcription of these subunits in the models that I have already 
described. I selected the time points of maximal gene transcription for laminin alpha 
5 (day 7 in the Mdm2 model and day 12 in the DDC model) and performed qPCR 
using whole liver tissue. 
In the Mdm2 model (figure 3.11A), both the α3 and α6 integrin subunits are 
upregulated approximately 10-fold during regeneration, with no change in α7 
expression. The β1 integrin subunit is upregulated 2.7-fold, and there is a trend 
towards an increase in β4 integrin (p 0.11). 
In the DDC model (figure 3.11B), both α3 and α6 integrins are again upregulated 
(1.8 and 4.9-fold, respectively), whereas α7 integrin is down-regulated. There is no 
change in β1 expression and a 3.0-fold increase in β4 integrin. 
Alpha 3 integrin only associates with beta 1 integrin, and has no other known binding 
partners. The failure to demonstrate upregulation of the corresponding beta 1 subunit 
in the DDC model may be due to a switch of existing beta 1 integrin from one or 
more of its other binding partners to favour alpha 3 integrin, rather than requiring 
increased synthesis. 
Alpha 6 integrin may associate with either beta 1 or beta 4 integrin. It is not clear 
from the data presented which of these is the main binding partner in this context, 
and it is possible that both are present. 
Although these data suggest an increase in gene expression for various laminin-
binding integrins at a time that corresponds to HPC expansion, it is not clear whether 
the integrins are expressed on the HPCs. It is also worth acknowledging here that 
integrin function is not necessarily regulated at a transcriptional level. Integrin 
affinity can be regulated by intracellular signals that result in conformational 
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changes, so-called inside-out signalling. Therefore an increase in gene transcription 
is not equivalent to an increase in integrin signalling. Nevertheless, this data 
identifies potential laminin-binding receptors to investigate further.   
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Figure 3.11 – Expression of laminin-binding integrins during regeneration 
A. AhCre+ Mdm2flox/flox mice aged 12-16 weeks were given a single dose of 20 
mg/kg beta-napthoflavone by i.p. injection. Integrin subunits were assessed by qPCR 
of whole liver tissue, which showed upregulation of alpha 3, alpha 6 and beta 1 
subunits during HPC expansion. n=6 animals at day 0, n=4 animals at day 7. B. The 
same analysis was performed in S129 mice aged 6-8 weeks given diet containing 
0.1% DDC. n=8 animals per group. In this case, there was upregulation of alpha 3, 
alpha 6 and beta 4 subunits during the HPC response. All data are shown as median 
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HPCs express laminin-binding integrins 
Having demonstrated an increased expression of various integrin subunits at the 
whole tissue level, I wanted to establish whether any of these were expressed on the 
HPCs themselves. I therefore performed immunohistochemistry on liver sections 
from the Mdm2 model. Alpha 3 integrin did not appear to be expressed on HPCs, 
whereas both alpha 6 integrin and beta 1 integrin do appear to colocalise with HPCs. 
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Figure 3.12 – HPCs express laminin-binding integrins 
A-C. Immunohistochemistry on frozen sections from the Mdm2 model. Livers 
harvested 10 days after induction with 20mg/kg beta-naphthoflavone. A. HPC 
marker A6 (red) and integrin alpha 3 (green) show separate non-overlapping staining 
patterns. B. HPC marker panCK (red) and integrin alpha 6 (green) appear to co-
localise. C. HPC marker panCK (red) and integrin beta 1 (green) also appear to be 
co-expressed, although beta 1 integrin is also expressed across the other non-
progenitor cells. Original magnification x200. Scale bar represents 50 µm. 
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3.3 Discussion 
Although the association between HPCs and extracellular laminins is well-described, 
the detailed composition of the laminin isoforms in this setting has not been 
described.  
In order to study this further, I have first refined a model of HPC expansion in the 
context of hepatocellular injury. The Mdm2 mouse model allows conditional deletion 
of MDM2 within hepatocytes in response to the xenobiotic beta-naphthoflavone. I 
have demonstrated that a single low dose of beta-naphthoflavone (20 mg/kg) 
administered intraperitoneally is sufficient to stimulate robust progenitor cell 
expansion that peaks 7-10 days after induction. I have compared this with the DDC 
model, in which mice are fed a diet containing the toxin DDC to stimulate progenitor 
cell expansion associated with biliary regeneration. 
In both mouse models, there is upregulation of laminin alpha 5 gene transcription, 
with increased deposition in the periportal region. This laminin alpha 5 closely 
associates with the HPCs, forming a basement membrane-like structure around the 
ductules. Laminin alpha 5 is also shown in the ductular reaction seen in human liver 
disease.   
The laminin alpha 5 chain occurs predominantly as laminin-511, which is found in 
epithelia, endothelia and smooth muscle. It can also form laminin-521 which has a 
similar distribution but is also found at the neuromuscular junction and in the 
glomerular basement membrane within the kidney. Lastly, it can occur as laminin-
523 which is described in the retina and central nervous system. As the beta and 
gamma chains tend to have less marked variation, I have not characterised these to 
date. However, both the beta and gamma chains are capable of influencing receptor 
binding to some degree (Taniguchi et al., 2009, Ido et al., 2008). It would therefore 
be of interest to further delineate the other laminin chains involved in HPC 
expansion.  
Laminin alpha 5 is the main alpha chain seen around mature bile ducts (Kikkawa et 
al., 2005). Given the origin of HPCs from the canals of Hering and the continued 
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expression of a number of biliary markers, it is perhaps not surprising that this is the 
main isoform expressed during HPC expansion. However, this is in contrast to the 
laminin which is transiently expressed in the liver following partial hepatectomy, 
which is predominantly laminin alpha 1. 
Laminin alpha 5 has been shown to have an important role in the morphogenesis of a 
number of tissues, including teeth (Fukumoto et al., 2006), hair (Li et al., 2003a), 
small intestine (Mahoney et al., 2008), lung (Nguyen et al., 2005) and submandibular 
gland (Rebustini et al., 2007). There is also work showing increased expression of 
laminin alpha 5 in human malignancies, including colorectal and breast cancers 
(Hewitt et al., 1997). However, there is little work looking at laminin-511 in relation 
to adult tissue stem cells. 
I have isolated both stellate cells and hepatic progenitor cells from the Mdm2 model, 
using density centrifugation and selective culture conditions. There was a non-
significant trend towards higher expression of laminin alpha 1 and alpha 2 mRNA by 
cultured stellate cells compared to progenitors, in comparison to higher laminin alpha 
5 mRNA expression by progenitors. Similar results are seen using a published 
microarray result, using FACS-isolated cells from mice fed a DDC diet. A 
progenitor-enriched population showed significantly higher expression of laminin 
alpha 5 and lower levels of alpha 1 and alpha 2 than the progenitor-depleted 
population.  
These results are consistent with other related work in the field. During regeneration 
after partial hepatectomy, the increase in laminin alpha 1 was produced by stellate 
cells (Kikkawa et al., 2005). During fetal liver development where laminin alpha 5 
has been shown to play a role, this is produced by the hepatoblasts themselves 
(Tanimizu et al., 2012). Although my work suggests that HPCs represent a 
significant source of laminin alpha 5 during regeneration, this is not proven beyond 
doubt. The methods of cell purification are not completely specific and there is likely 
to be a degree of contamination with other cell types. Furthermore, I did not look at 
other cell types such as endothelial cells. This could be addressed by using in situ 
hybridisation on liver sections from both models to provide a more accurate 
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comparison of all of the possible cellular sources of laminin alpha 5, but it was felt 
that this was beyond the scope of this thesis.  
Finally, I have shown that there is increased expression of certain subunits of 
laminin-binding integrins (α3, α6, β1 and β4) during HPC expansion. It is important 
to note when considering the qPCR data that integrin function may not relate directly 
to transcription levels, as conformational changes play a significant role in regulating 
their activity. Furthermore, some subunits (especially β1) exist in multiple pairings 
and so a switch in binding partner may occur without requiring an increase in 
transcription. The α6 and β1 subunits appear to co-localise with the HPCs, 
suggesting a possible mechanism by which the extracellular laminin could modulate 
HPC behaviour. 
The descriptive work outlined in this chapter identifies laminin alpha 5 as the 
predominant alpha chain expressed around HPCs, and led me to perform further 
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Chapter 4: Defining the effects of laminin 




Having established a specific pattern of laminin alpha chain expression, I then 
wanted to investigate the ability of the different laminin alpha chains to influence 
hepatic progenitor cell behaviour. In order to assess this, I have performed a number 
of in vitro experiments. 
I have used the Bmol cell line which is derived from adult hepatic progenitor cells 
isolated from mice fed a CDE diet and which have undergone spontaneous 
immortalisation (Tirnitz-Parker et al., 2007). Following liver digestion, a Percoll 
density centrifugation gradient was used to generate primary cultures that were 50-
80% pure for A6-positive and K19-positive cells by day 7. Colonies were trypsinised 
and serially diluted to obtain single cell cultures, some of which overcame growth 
inhibition to form clonally-derived lines. Bmol cells express phenotypic markers of 
both biliary and hepatocytic lineages, and can be differentiated towards hepatocytes 
using dexamethasone with insulin-transferrin-selenium and nicotinamide. 
To look at specific laminin chains, I have used commercially-available recombinant 
laminins. These are produced from transfected human embryonic kidney cancer cells 
(HEK293) and purified using chromatography (Doi et al., 2002). In order to 
selectively study the effects of the alpha chains, I compared isoforms that all shared 
the common beta-1 and gamma-1 chains: laminin-111, -211, -411 and -511. The 
laminin-311 isoform is not available commercially and is relatively uncommon, as 
the alpha-3 chain occurs predominantly as the trimer laminin-332. In the previous 
chapter, I have shown that the alpha 3 chain is down-regulated in both models of 
HPC expansion so I felt that this was not a major omission.  
In this chapter, I briefly compare the laminin alpha chain expression profile of the 
Bmol cell line with the HPC models presented in the previous chapter. I then use 
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exogenous recombinant laminins to examine the effect of specific laminin alpha 
chains on cell adhesion, migration, proliferation and differentiation. In order to 
demonstrate the effect of endogenous laminin synthesis on proliferation and 
differentiation, I also use small interfering RNA (siRNA) to laminin alpha 5.  
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4.2 Results 
 
Validation of the progenitor characteristics of the Bmol cell line 
Prior to using this cell line for experiments, I first established that they showed the 
expected characteristics of adult hepatic progenitor cells. As there is no universal 
specific marker for HPCs, I have tested for a panel of markers that have been shown 
to be present on progenitors. Bmols all express the HPC markers that I used in the 
previous chapter, namely pancytokeratin, keratin-19 and osteopontin (figure 4.1A-
C). Bmols also stained for MIC1-1C3 (figure 4.1D), an antibody that enriches for 
bipotential clonogenic adult progenitors (Dorrell et al., 2011), and sox9 (figure 4.1E), 
a nuclear transcription factor that has been shown to label HPCs in a lineage tracing 
experiment (Furuyama et al., 2011).  
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Figure 4.1 – Bmols express adult hepatic progenitor cell markers 
Bmol cells grown on tissue culture plastic were stained using immunofluorescence 
for the liver progenitor cell markers pancytokeratin (A), keratin-19 (B), osteopontin 
(C), MIC1-1C3 (D) and sox9 (E). Controls performed for each antibody using 
species-matched serum in place of the primary antibody and photographed on the 
same exposure showed no staining. A representative example is shown for 
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Bmols show a similar pattern of laminin expression to primary HPCs 
I have shown in the previous chapter that primary HPCs in culture express laminin 
alpha 5. I wanted to see whether Bmols shared the same pattern of laminin 
expression. 
I performed qPCR on cell lysate from Bmols grown on tissue culture plastic, looking 
at the five laminin alpha chains (figure 4.2A). In order to provide a relative level to 
aid interpretation, I have compared this to the baseline level of expression of each 
chain in normal mouse liver. It can be seen that laminin alpha 1, alpha 2 and alpha 3 
are expressed at much lower levels by Bmols than in normal liver. In contrast, 
laminin alpha 5 is expressed at a higher level in Bmols than in normal liver. 
Furthermore, laminin alpha 5 synthesis by Bmols can be demonstrated by 
immunocytochemistry (figure 4.2B). This suggests that Bmols do express laminin 
alpha 5 in a similar manner to primary HPCs. 
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Figure 4.2 – Bmols synthesise laminin alpha 5 
A. qPCR for laminin alpha chains, comparing cell lysate from Bmols cultured on 
plastic to expression levels in normal liver. Laminin alpha 5 is expressed at higher 
levels by Bmols than in normal liver, in contrast to all of the other laminin alpha 
chains. n=4 samples per group. Bars represent median +/- interquartile range. Data 
analysed by Mann Whitney test. *p<0.05. B. Bmols grown on tissue culture plastic. 
Immunofluorescence for laminin alpha 5 (red) and DAPI (blue) confirms laminin 
alpha 5 production at a protein level. Original magnification x320. Scale bar 
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Adhesion of HPCs to laminins 
Adhesion of cells to a substrate can be measured in a number of ways (Humphries, 
2009). I have chosen two assays to quantify the adhesion of Bmols to the different 
laminin isoforms: a spreading assay which measures the extent of flattening of 
adherent cells using image analysis, and an attachment assay which uses a 
colorimetric detection of the number of bound cells after washing. 
When Bmols are plated onto either untreated tissue culture plastic, the majority of 
cells remain rounded after an hour (figure 4.3A). The same is observed when cells 
are plated on laminin-111, -211 and -411 (figure 4.3B-D). When plated on laminin-
511, however, Bmols rapidly flatten and spread (figure 4.3E). Average cell area was 
quantified using image analysis software, and was significantly greater on laminin-
511 than any of the other matrices (figure 4.3F).  
As discussed earlier, a number of cell surface receptors can mediate the interaction 
between cells and extracellular laminin. The majority of laminin-binding integrins 
share the common beta-1 subunit. The addition of a blocking antibody against beta-1 
integrin reduces cell spreading on laminin-511 (figure 4.3G), although it did not 
return it to the level seen on plastic. In contrast, an alpha-6 integrin blocking 
antibody did not have a significant effect on cell spreading. 
An attachment assay measured the number of cells that remained adherent after 
washing. This confirmed significantly greater adhesion to laminin-511 than other 
matrices (figure 4.3H). Again, cell attachment to laminin-511 was reduced by a 
blocking antibody to beta-1 integrin, but not by a blocking antibody to alpha-6 
integrin (figure 4.3I). Although a formal dose-response curve was not performed, 
doubling the concentration of the blocking antibody did not increase the level of 
attachment, suggesting that other receptors are likely to be involved. 
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Figure 4.3 - Bmols adhere preferentially to laminin-511 
Tissue culture wells were coated with 20 µg/ml of the various recombinant laminins. 
One hour after plating, phase contrast microscopy shows that Bmols remain small 
and rounded on plastic (A), laminin-111 (B), laminin-211 (C) and laminin-411 (D). 
In contrast, cells plated on laminin-511 (E) show evidence of flattening and 
spreading. Original magnification x400 for all conditions. Scale bars represent 25 
µm. F. Image analysis of cell spreading confirms a significantly larger cell area on 
laminin-511 than any of the other matrices. Results show the average area of 100 
cells per group. G. Cell spreading of Bmols plated on laminin-511 after pre-
incubation with blocking antibodies to α6 and β1 integrin subunits or their isotype 
controls. Results show the average area of 100 cells per group. H. A colorimetric 
assay to assess the number of bound cells shows significantly greater cell attachment 
on laminin-511 relative to the other matrices. n=4 wells per group. I. Attachment of 
Bmols to laminin-511 after pre-incubation with blocking antibodies to α6 and β1 
integrin subunits or isotype controls. n=4 wells per group. 
In all graphs, bars represent median +/- interquartile range. Data comparing matrices 
were analysed by Kruskal-Wallis test, with Dunn’s post-test comparison for each 
group against plastic. Data comparing integrin-blocking antibodies used Mann 
Whitney tests for each antibody and its isotype, *p<0.05, **p<0.01, ***P<0.001. 
Data shown in each graph represents the results from a single experiment but all 
results were confirmed in at least one independent replicate. 
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Migration of HPCs on laminins 
In order to assess migration, cells were pre-treated with mitomycin C to inhibit 
proliferation and plated at a confluent density around a central plug. Removal of the 
plug created a standardised circular area into which cells could migrate (figure 4.4A). 
After 24 hours, cells were fixed, stained and photographed. Although there was some 
migration of cells on untreated plastic (figure 4.4B), this was enhanced on laminin-
511 (4.4C). The extent of cell migration was then quantified using image analysis 
software. Migration was significantly greater on laminin-511 than any of the other 
laminin isoforms (figure 4.4D-E). Pre-treatment with blocking antibodies against 
alpha-6 or beta-1 integrin did not significantly affect this, although there was an 
apparent trend towards a reduction with both antibodies (figure 4.4F). 
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Figure 4.4 – Bmols migrate preferentially on laminin-511 
A-C. Cells fixed and stained at the start of the migration assay (A) show a central 
defect into which cells migrate over 24 hours on both plastic (B) and laminin-511 
(C). Original magnification x40. Scale bars represent 500 µm. D. Migration occurs 
significantly more on laminin-511 than on any of the other surfaces. n=4 wells per 
group. Analysed by Kruskal-Wallis test with Dunnett’s post-test analysis to compare 
each matrix against untreated plastic. **p<0.01. Data shown represent the results 
from a single experiment but were confirmed in two independent replicates. Scale 
bar represents 500 µm. E. Although there was a trend towards a reduction in 
migration with both alpha 6 and beta 1 integrin-blocking antibodies, neither reached 
statistical significance consistently. The graph shows the combined results of 3 
independent replicates, with n=4 wells per group in each experiment. 
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Proliferation of HPCs on recombinant laminins 
In order to assess for differences in proliferation, I first used an MTT assay. This test 
utilises the ability of cells to convert the yellow dye 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) to purple formazan. The rate of conversion 
under defined conditions relates to the number of viable cells present. This has the 
advantage of being a simple colorometric assay that can be readily performed in 
multiple wells. However, it should be noted that it will be affected by both cell 
proliferation and cell death. I therefore went on to also use 5-ethynyl-2’-
deoxyuridine (EdU) incorporation as a more specific measure of cell proliferation. 
To determine the appropriate number of cells to use for the MTT assay for the Bmol 
cell line, I performed an optimisation experiment. Figure 4.5A compares 3 different 
cell numbers (2500, 5000 and 10,000) assessed at 4 timepoints (0, 24, 48 and 72 
hours after plating). It can be seen that an initial population of 5000 cells per well 
expands over 48-72 hours to provide easily detected colour change in the MTT 
assay. Increasing the starting cell number to 10,000 does increase the absorbance 
reading further but with an apparent levelling off between 48 and 72 hours. This may 
be due either to saturation of the read-out or contact inhibition of cells. I therefore 
decided to use 5000 cells per well as the starting number for subsequent experiments. 
I then performed the MTT assay in wells coated with the recombinant laminin 
isoforms. Culturing Bmols on different laminin isoforms under standard conditions 
did not result in any measurable difference in cell number (figure 4.5B).  
As the MTT assay measures the number of viable cells rather than proliferation per 
se, it is possible that an effect on proliferation is masked by changes in cell loss. I 
therefore went on to assess proliferation directly by measuring DNA synthesis. 5-
ethynyl-2’-deoxyuridine (EdU) is a nucleoside analogue of thymidine that is 
incorporated into DNA during S-phase, which can be detected using a click reaction. 
Figure 4.5C shows an example of EdU staining. All nuclei are stained blue by DAPI, 
and those of cells in S-phase will also appear green as a result of EdU staining.  
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Figure 4.5D shows the effect of culturing cells on different laminin alpha chains on 
EdU incorporation. The proportion of cells incorporating EdU was not significantly 
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Figure 4.5 Proliferation of HPCs on recombinant laminins 
A. Optimisation of the MTT assay for Bmols, comparing the effects of starting cell 
number and duration of culture on MTT dye conversion. A starting population of 
5000 cells per well was selected for the optimal change in read-out after 48-72 hours. 
n=6 wells per group. B. Coating the wells with recombinant laminins did not produce 
any detectable change in the rate of MTT dye conversion. n=6 wells per group, 
Kruskal-Wallis p 0.07. Results are shown for a single experiment but this was 
confirmed in an independent replicate. C. Fluorescent staining of EdU incorporation 
by Bmols (EdU, green; DAPI, blue) was used to detect actively proliferating cells. 
Original magnification x200. Scale bars represent 50 µm. D. Quantification of EdU 
incorporation by Bmols after 48 hour incubation on recombinant laminin chains did 
not show any significant difference in rates of proliferation, Chi-squared test p 0.56. 
Cells were quantified in 5 low-powered (x20) fields per group. Data shown represent 
the results from a single experiment but these results were confirmed in an 
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Effect of serum concentration on Bmol response to recombinant 
laminins 
It has been suggested that using high concentrations of serum in cell culture 
experiments may mask an effect of extracellular matrix. I therefore looked at the 
effect of reducing the serum concentration on cell viability in cells grown both on 
tissue culture plastic and on recombinant laminins. 
Figure 4.6A shows the effect of reducing serum concentration on cells cultured on 
tissue culture plastic. It can be seen that there is only mild loss of cell viability with 
serum as low as 0.5%, but a marked drop in viability in serum-free conditions. 
I therefore re-assessed the effect of recombinant laminins on Bmols in both low-
serum (0.5%) and serum-free conditions. In low-serum conditions (figure 4.6B-C), 
cell number appears to be reduced in the presence of laminin-111, -211 and -411 
compared to untreated tissue culture plastic, but maintained on laminin-511. In 
serum-free conditions (figure 4.6D), there is marked cell death on all matrices but 
this is most marked on laminin-111 and -411, and the highest level of cell viability is 
seen on laminin-511. 
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Figure 4.6 Effect of varying serum concentration on proliferation 
A. MTT assay performed on Bmols cultured on plastic with varying concentrations 
of fetal calf serum (FCS) shows a marked drop in cell viability in serum-free 
conditions. n=6 wells per group in a single experiment. B. Representative pictures of 
phase microscopy of cells cultured on recombinant laminins in the presence of 0.5% 
FCS, following administration of MTT. There are appear to be fewer cells on 
laminin-111, -211 and -411. Original magnification x40. Scale bars represent 250 
µm. C. This was quantified using the colorimetric MTT assay, confirming lower 
numbers of viable cells on laminins other than laminin-511. n=12 wells per condition 
in a single experiment. One-way ANOVA p 0.0009, post-test Dunnett’s comparison 
of each column versus plastic, *p<0.05. D. MTT assay on Bmols cultured on 
recombinant laminins in serum-free medium showed a higher number of viable cells 
on laminin-511 than either plastic or other recombinant laminins. n=6 wells per 
condition in a single experiment. One-way ANOVA p<0.001, post-test Dunnett’s 
comparison of each column versus plastic, *p<0.05. All columns represent mean, 
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Proliferation of HPCs following knock-down of laminin alpha 5 
As I have already demonstrated that Bmols synthesise laminin alpha 5, it is possible 
that an effect of exogenous matrix is being masked by endogenous matrix 
production. This is unlikely to be significant over the one hour time-frame of the 
adhesion assays but may well influence outcome over the longer periods of culture 
(48-72 hours) required for proliferation assays. To investigate this possibility, I used 
small interfering RNA (siRNA) to knock-down endogenous laminin alpha 5 
production. 
I initially compared 4 siRNA sequences directed specifically against laminin alpha 5, 
a scrambled sequence and untransfected cells. Figure 4.7A shows the efficiency of 
knock-down for each of the sequences, as determined by qPCR. It can be seen that 
there is a degree of non-specific knock-down with the scrambled sequence. Knock-
down efficiencies assessed at 24 hours after transfection were expressed as a 
proportion of the level of gene expression seen with the scrambled sequence. Knock-
down of 65% and 79% were seen with sequences 2 and 3. Increasing the 
concentration of siRNA and the concentration of transfection reagent did not 
significantly alter the transfection efficiency. These sequences were then evaluated at 
a protein level, using an ELISA against laminin alpha 5. The results are shown in 
figure 4.7B, and confirmed a marked reduction in laminin alpha 5 synthesis 
following the siRNA treatment.   
Figure 4.7C shows the effect of laminin alpha 5 knock-down on the number of viable 
cells, as determined by an MTT assay. There was a significant reduction in the cell 
number with both sequences, when compared to the scrambled sequence. 
As discussed previously, the change in MTT could reflect an alteration in either cell 
proliferation or cell death. I therefore used EdU incorporation to determine cell 
proliferation rates in response to the siRNA. Figure 4.7D shows a marked reduction 
in the proportion of EdU-positive cells following siRNA against laminin alpha 5 
(12% and 20%, compared with 51% in those treated with the scrambled sequence). 
This suggests that endogenous laminin alpha 5 production supports cell proliferation.  
 




Defining the effects of laminin isoforms in vitro  117 
Figure 4.7 Proliferation of HPCs following knock-down of laminin alpha 5 
A. qPCR for laminin alpha 5 expression relative to housekeeping gene PPIA, in cells 
treated with siRNA against laminin alpha 5 or a scrambled sequence. All values are 
normalised to the level of the scrambled sequence. Greatest knock-down is seen with 
sequences 2 and 3. n=3 independent samples per group. Kruskal-Wallis p 0.029. B. 
ELISA for laminin alpha 5 protein expression, normalised to total protein level, 
confirms knock-down with these sequences. n=3 independent samples per group. C. 
MTT performed 48 hours after transfection with siRNA or scrambled sequence 
shows a reduction in the number of viable cells following siRNA treatment. n=6 
wells per group. Kruskal-Wallis test p 0.0036, post-test Dunnett’s analysis for each 
siRNA vs scrambled *=p<0.05, **=p<0.01. D. Quantification of EdU incorporation 
confirms a lower proportion of proliferating cells following siRNA treatment. Cells 
were quantified in 5 low-powered fields per condition. Chi-squared p < 0.001. Data 
shown in C and D each represent the results from a single experiment but both were 
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Differentiation of HPCs on laminins 
In order to look for an effect of laminin isoforms on differentiation, I cultured Bmols 
for 72 hours in wells coated with the different recombinant laminins, and then 
harvested the cells for RNA extraction. Given the previous observations about the 
effect of serum in potentially masking a matrix effect, these experiments were done 
in 0.5% FCS. It can be seen from figure 4.8A-E that there were some morphological 
differences between cells grown on the different laminin isoforms. Whereas Bmols 
usually form clusters or islands of cells, Bmols cultured on laminin-511 appeared to 
remain separate with less cell-cell contact. 
The progenitor cell markers EpCAM (figure 4.8F) and keratin-19 (figure 4.8G) were 
unaffected by the presence of exogenous laminins. In contrast, albumin transcription 
(figure 4.8H) was significantly reduced in the presence of all of the laminin isoforms, 
but most markedly in response to laminin-511. In view of the apparent reduction in 
cell-cell contact seen on phase contrast microscopy, I also looked at expression of E-
cadherin (figure 4.8I). This was markedly reduced in the presence of both laminin-
411 and -511.  
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Figure 4.8 – Liver progenitor cells differentiation on matrix 
A-E. Phase contrast microscopy of Bmol cells cultured on recombinant laminins for 
72 hours shows a reduction in cell-cell contact in cells on laminin-511. Original 
magnification x100. Scale bars represent 100 µm. F-I. qPCR for differentiation 
markers in cells cultured on the different laminins. n=3 wells for each condition. 
There is no difference in EpCAM (F), p 0.97 or K19 (G), p 0.11. There is lower 
expression of albumin (H) by cells cultured on all of the laminins, but especially 
laminin-511, p 0.0003. Laminin -411 and -511 are also associated with a reduction in 
expression of e-cadherin (I), p 0.002.  
Data are shown as mean, error bars represent standard error of mean. Analysed by 
One-way ANOVA with Dunnett’s post-test comparison, for each column versus 
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Differentiation of HPCs following knock-down of laminin alpha 5 
Using the same siRNA knock-down described earlier, I inhibited endogenous 
laminin alpha 5 production and looked at changes in cell differentiation at 72 hours. 
Figure 4.9 shows the morphology of untransfected Bmols (A), compared with those 
treated with a scrambled sequence (B) and siRNA sequences directed against laminin 
alpha 5 (C,D). In both siRNA sequences, cells appear larger. 
The progenitor cell marker EpCAM (figure 4.9E) was reduced by one of two siRNA 
sequences, relative to scrambled sequence. As this was limited to a single sequence, 
it is difficult to know whether this is of functional significance. A similar pattern is 
seen with K19 (figure 4.9F). However, albumin transcription was significantly 
increased by both siRNA sequences (figure 4.9G), suggesting differentiation towards 
a hepatocytic lineage. Despite the changes seen with exogenous laminins previously, 
transcription of e-cadherin (figure 4.9H) was not significantly altered by knock-down 
of laminin alpha 5. 
Having shown that both exogenous and endogenous laminin alpha 5 inhibits 
differentiation towards a hepatocytic lineage, I wanted to see if induction of 
differentiation would result in a reduction in laminin synthesis. Oncostatin M has 
been shown to induce differentiation of rat liver progenitor cells towards a 
hepatocytic phenotype (Okaya et al., 2005). Bmols were cultured on tissue culture 
plastic in the presence or absence of oncostatin M for 5 days and then harvested for 
RNA extraction. Figure 4.9I shows a trend towards a reduction in laminin alpha 5 
synthesis by the differentiated cells. 
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Figure 4.9 Differentiation of HPCs following knock-down of laminin alpha 5 
A-D. Phase contrast microscopy of untransfected Bmols (A), Bmols treated with a 
scrambled sequence (B) and with targeted Lama5 siRNA sequences 2 (C) and 3 (D). 
Scale bars represent 100 µm. E-H. qPCR from cells 72 hours after treatment with 
siRNA. n=3 wells per group. Gene expression is normalised to the level of the 
housekeeping gene PPIA and analysed by one-way ANOVA, with Dunnett’s post-
test comparison for each sequence compared to scrambled. E. EpCAM expression is 
reduced with just one of two siRNA sequence, p 0.0003. F. Similarly, K19 
expression is reduced by one sequence, p 0.0022. G. Albumin expression is reduced 
in response to both siRNA sequences, p 0.0029. H. E-cadherin is unaffected by 
laminin alpha 5 siRNA, p 0.37. I. Laminin alpha 5 transcription by Bmols in 
standard media (control) and in media containing oncostatin M (differentiated) 
shows a trend towards a reduction in laminin alpha 5 synthesis as cells differentiate 
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4.3 Discussion 
In this chapter, I have confirmed that the Bmol cell line shares the characteristic 
markers of the adult hepatic progenitor cells that I described in the previous chapter. 
In particular, I have demonstrated that Bmols synthesise laminin alpha 5. 
Using recombinant human laminins, I have demonstrated that Bmols adhere 
preferentially to laminin-511, as compared to laminin-111, -211, -411 or tissue 
culture plastic. This effect is partly but not completely blocked by antibodies against 
beta-1 integrin. Bmols also migrate more on laminin-511 than any of the other 
matrices.  
When Bmols are cultured in 2% FCS, the presence of recombinant laminins did not 
affect cell proliferation as measured by either MTT assay or EdU incorporation. 
However, in low (0.5%) serum or serum-free conditions, laminin-511 was associated 
with higher cell viability. Similarly, knock-down of laminin alpha 5 using siRNA 
reduced cell numbers and proliferation. 
Culturing Bmols on laminin-511 resulted in a reduction in albumin transcription, 
with no significant effect on progenitor cell markers. Conversely, siRNA knock-
down of laminin alpha 5 increased albumin transcription. This suggests that 
endogenous laminin alpha 5 production by Bmols is helping to maintain the cells in a 
relatively undifferentiated state. As the cells were differentiated towards hepatocytes 
using oncostatin M, there was a trend to a reduction in laminin alpha 5 production. 
The effects on adhesion and migration is perhaps not surprising as laminin-511 has 
been shown to be a potent adhesive and pro-migratory substrate for a number of 
tumour cell lines (Pouliot and Kusuma, 2013). It has even been suggested that 
laminin-511 plays a role in metastatic progression of breast cancer in a mouse model 
(Chia et al., 2007). However, I am not aware of any such effect on adhesion or 
migration being demonstrated for adult progenitor cells.  
Although I did not use any matrix containing laminin alpha 3 (for reasons outlined 
earlier in the chapter), there is an intriguing suggestion from work on kidney 
epithelial cells that migration may be regulated by a haptotactic gradient formed by 
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both laminin-511 and -332 (Greciano et al., 2012). Given the consistent down-
regulation of laminin alpha 3 chain seen in both models of HPC expansion in chapter 
3, it is feasible that a similar polarity or gradient is important for HPCs. However, 
this requires further work to confirm such a mechanism. 
The idea of laminin-511 acting in an autocrine fashion to regulate cell behaviour is 
not new, with a number of tumour cell lines that have been shown to synthesise, 
secrete and adhere to laminin-511 in culture (Kikkawa et al., 1998, Pouliot et al., 
2000, Oikawa et al., 2011). Intriguingly, different cell lines adhere through different 
receptors. For example, the adhesion of JAR choriocarcinoma cells to laminin-511 is 
mediated via α6β1 integrin whereas that of PANC-1 pancreatic adenocarcinoma cells 
is via α3β1, even though both cell lines express both integrin receptors. α1β1 and 
α6β4 integrins have also been shown to mediate adhesion to laminin-511 (Kikkawa 
et al., 2008, Pouliot et al., 2001). Part of this variability may be explained by the 
expression of co-receptors which modulate the effect of integrin-binding. One such 
candidate is CD151, a member of the tetraspanin family of cell-surface receptors (Ke 
et al., 2011). This has been shown to modulate the binding of beta-1 integrin to 
laminin-511 in vitro (Yamada et al., 2008). 
Although this work suggests a possible role for β1 integrin in mediating some of the 
interaction between HPCs and laminin-511, this only appears to account for a small 
part of the effect on adhesion. It is therefore likely that there are other receptors that 
are important in this. Potential candidates include β4 integrin, Lutheran/BCAM and 
syndecan. In particular, Lutheran is a highly specific laminin alpha 5 receptor and 
recent studies have shown an effective blocking antibody which could be used to 
explore this further.  
The effect on differentiation suggests a role for laminin-511 in maintaining a naïve 
phenotype. This is consistent with work in embryonic stem cells and induced 
pluripotent stem cells that has shown that laminin-511 promotes long-term self-
renewal and expression of the pluripotency markers OCT4, Nanog and SOX2 (Rodin 
et al., 2010). 
 
Defining the effects of laminin isoforms in vitro  127 
A number of intracellular signalling pathways have been implicated in the effects of 
laminins on cellular behaviour. In particular, laminin-511 has been shown to affect 
the Wnt and Hedgehog pathways. Work looking at embryonic hair morphogenesis 
has shown that exogenous noggin or sonic hedgehog (Shh) are able to restore the 
changes in follicle development that are seen in laminin alpha 5-null mice (Gao et 
al., 2008). Laminin-511 appears to stimulate noggin, leading to LEF-1 expression 
and amplification of Shh signalling. In addition, studies of the small intestine of 
laminin alpha 5 knock-out mice identified changes in the Wnt and PI3K/Akt 
pathways (Ritie et al., 2012). Laminin alpha 5 appears to repress canonical Wnt 
signalling, and activate PI3K/Akt signalling. Although I have not assessed 
intracellular signalling pathways as part of this thesis, the same techniques described 
here could be applied to this. 
One of the main concerns is interpreting this in vitro work is whether Bmols are truly 
representative of primary HPCs. In particular, a cell line that has undergone 
immortalisation may not behave in the same way as primary cells with regard to 
proliferation and differentiation. However, I chose not to use primary HPCs for these 
experiments for several reasons. At present, no specific cell surface markers have 
been identified that can accurately discriminate between progenitors and biliary 
epithelial cells. Progenitor cell isolation protocols therefore rely on a period of 
culture on matrix components to purify the cell populations, and this in itself may 
alter both cell surface receptor expression and cell behaviour. Furthermore, it is 
difficult to ensure reproducibility of cell purity between experiments using primary 
cell cultures. As many of the in vitro techniques require relatively large numbers of 
cells, this would require very large number of mice. Bmols, in contrast, have the 
advantages of ready availability in large numbers and reproducibility. 
A further limitation is the use of a single cell type in culture experiments. I have 
already described the close association between HPCs and both hepatic stellate cells 
and macrophages. It is possible that cell-matrix interactions maybe modified in the 
presence of particular cell-cell signalling. Co-culture experiments may provide 
further information about how laminin alpha 5 influences the interactions between 
different cell types. However, even with co-cultures, it is not currently possible to 
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recreate the complexity of the HPC niche in culture. In the central nervous system, 
slice culture techniques have been used to maintain three-dimensional architecture 
whilst still allowing experimental manipulation of cells (Gahwiler et al., 1997). This 
technique has had limited success when applied to the liver but would be of great 
value if it could be developed further. 
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Chapter 5: Defining the effect of laminin alpha 5 
chain on progenitor cell behaviour in vivo 
 
5.1 Introduction 
Having established a selective effect of laminin-511 on HPC behaviour in vitro, I 
then sought to confirm this effect in vivo by knocking down laminin alpha 5 
synthesis. As the adhesion of HPCs to laminin-511 appeared to be at least partly 
mediated by beta-1 integrin, I also examined the effect of interfering with cell-matrix 
interactions by knocking down beta-1 integrin. As both of these genes are critical for 
embryonic development, their role in the regulation of adult liver regeneration cannot 
be assessed using conventional knock-out mice. However, as previously discussed, 
the use of Cre-lox technology allows targeted deletion of genes in a tissue- and time-
dependent manner. This permits the knock-down of gene expression in the adult 
following normal embryonic development. 
  
5.2 Results 
Use of transgenic mice to study matrix effects in vivo 
A tamoxifen-inducible Cre recombinase (Cre
ERT
) was knocked into the endogenous 
keratin-19 (K19) locus. Recombined cells were irreversibly labelled by inducing 
expression of yellow fluorescent protein (YFP) using a loxP-STOP-loxP-YFP 
sequence in the ROSA26 locus, as illustrated in figure 5.1A. The K19-CreERT was 
initially described as an inducible marker of endodermally-derived epithelial cells, 
and labelled cells within the stomach, intestine, pancreas and liver (Means et al., 
2008). Within the liver, K19 is expressed on biliary epithelial cells but is also a 
recognised marker of progenitor cells. 
The K19-CreERT mouse was then crossed with one of two possible floxed alleles: 
laminin alpha 5 or beta-1 integrin. Mice were bred to homozygosity for the floxed 
gene alleles and for the YFP reporter allele. The Cre transgene was maintained as a 
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heterozygote. This generated 3 separate strains of mice for comparison (as illustrated 
in figure 5.1B): 
K19-CreERT with a YFP reporter and no additional floxed alleles 
K19-CreERT with a YFP reporter and a floxed laminin alpha 5 gene 
K19-CreERT with a YFP reporter and a floxed beta-1 integrin gene 
The effect of recombination was studied in each of these strains using adult (6 week 
old) mice. In order to compare the hepatic progenitor cell response of these three 
strains, I used the DDC model described in chapter 3 to stimulate biliary 
regeneration. However, it was not possible to use the Mdm2 model to simulate 
hepatocellular regeneration with these strains as there would be cross-reactivity 
between the two Cre-lox systems. I therefore used a second dietary model, the 
choline-deficient ethionine-supplemented (CDE) diet, to stimulate HPCs instead. 
Choline is an essential nutrient with roles in cell membrane integrity, transmembrane 
signalling and phosphatidylcholine synthesis. Choline deficiency promotes hepatic 
steatosis (Zeisel and Blusztajn, 1994). The three dietary conditions are shown in 
figure 5.1C. 
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Figure 5.1 – Experimental design for transgenic model 
A. Illustration of the genetic construct of the K19-CreERT and YFP reporter. 
Tamoxifen-induced recombination results in YFP activation in K19-expressing cells. 
B. This reporter can then be combined with other floxed alleles, to examine the 
effects of conditional loss of gene expression during regeneration. The illustration 
shows the three experimental combinations used in this chapter: YFP reporter alone, 
floxed laminin alpha 5 and floxed beta-1 integrin. C. 6 week old mice from all three 
genotypes were exposed to normal chow, CDE and DDC diets to examine the effects 
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K19-Cre labels bile ducts and progenitor cells 
Although the YFP should be able to be visualised directly on frozen tissue sections 
using fluorescence microscopy, I fixed the tissue using formaldhyde in order to 
improve the preservation of morphological detail. The YFP was then detected using 
an antibody against green fluorescent protein (GFP), which could be visualised with 
either DAB or fluorescence. This method of visualisation had the additional benefit 
of allowing signal amplification. 
In Cre-negative mice given tamoxifen (figure 5.2A) or Cre-positive mice in the 
absence of tamoxifen (figure 5.2B), there is no detectable YFP staining. However, 
Cre-positive mice given tamoxifen demonstrate YFP expression in a proportion of 
biliary epithelial cells (BECs), as shown in figure 5.2C. This is quantified in figure 
5.2D, confirming the specificity of YFP labelling in this system. 
In approximately half of the mice with the floxed laminin alpha 5 gene, much more 
widespread labelling of perisinusoidal cells was seen (figure 5.2E). This pattern was 
very unexpected and only present in some of the animals, with the remaining mice 
showing a predominantly biliary pattern. Subsequent discussions with the 
collaborator who supplied the mice with the floxed laminin alpha 5 gene revealed 
that although the original breeding pair had been genotyped as ‘Cre-negative’, they 
were from a colony that had contained a HoxB7-Cre-EGFP construct. Re-testing of 
my experimental animals confirmed that those with the widespread perisinusoidal 
YFP expression all had the HoxB7-Cre-EGFP, whereas the animals with the 
peribiliary YFP expression lacked this and had the expected K19-Cre. The HoxB7-
Cre-EGFP mice were therefore excluded from any further analysis, resulting in a 
marked reduction in the experimental numbers within the floxed laminin alpha 5 
groups (n=3-4, rather than the planned n=8). 
The YFP co-localises with the progenitor cell markers panCK (figure 5.2F) and 
osteopontin (figure 5.2G). Finally, a very small number of YFP-positive small 
hepatocyte-like cells were seen close to the bile ducts in mice on the CDE diet 
(figure 5.2H), consistent with HPC differentiation. 
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Figure 5.2 K19 labels bile ducts and progenitor cells 
A-C. Immunostaining for YFP in the absence of Cre (A) or in the absence of 
tamoxifen (B) shows no labelled cells, whereas Cre-positive animals given tamoxifen 
(C) show YFP-positive cells in a predominantly biliary distribution. D. 
Quantification of YFP expression in the previously-listed situations confirms the 
specificity of the Cre (n=3-4 animals per group). One-way ANOVA p<0.0001 E. 
Marked perisinusoidal cell labelling in mice was found in a proportion of mice with 
the floxed laminin alpha 5 gene, subsequently shown to have accidental HoxB7-Cre-
EGFP expression. These mice were excluded from further analysis. F. Dual 
immunofluorescence shows co-localisation of YFP (green) with panCK (red). 
Original magnification x400. G. Similarly, co-localisation of YFP (green) with 
osteopontin (red) confirms the labelling of HPCs. Original magnification x400. Scale 
bar represents 50 µm. H. YFP labelling of a small hepatocyte-like cell in close 
proximity to a bile duct in mice fed a CDE diet is consistent with the differentiation 
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The effect of loss of laminin alpha 5 or beta-1 integrin genes in the 
uninjured liver 
Recombination was induced in 6-week old mice of all 3 genotypes in the absence of 
any additional liver injury, as shown in figure 5.3A. There was no difference in the 
animals’ weights following recombination between the 3 groups (figure 5.3B). There 
was a slight increase in serum bilirubin in both the floxed laminin alpha 5 and floxed 
beta-1 integrin mice (figure 5.3C), consistent with a mild impairment of biliary 
epithelial cell function. There was little evidence to support any hepatocellular injury 
as a result of recombination, with normal serum ALTs in all groups (figure 5.3D). 
The serum albumin was unexpectedly slightly (but statistically significantly) higher 
in both of the floxed groups. Although this could theoretically be explained by 
premature differentiation of progenitors towards a hepatocytic lineage, histology to 
examine the morphology and distribution of YFP labelled cells did not show any 
evidence of this (figure 5.3F-H). 
Quantification of the number of YFP-positive cells showed a trend towards fewer 
YFP cells in the floxed laminin alpha 5 group (figure 5.3I). As the number of cells 
present will depend partly on the number and size of bile ducts present in the sections 
examined, the number of YFP-positive cells was calculated relative to the number of 
BECs present. Once this was taken into account, there was a significantly lower 
number of YFP-labelled cells in the floxed laminin alpha 5 group than either of the 
other two groups (figure 5.3J).   
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Figure 5.3 Effect of loss of laminin alpha 5 or beta-1 integrin in the uninjured liver 
A. Illustration of experimental timeline for transgenic mice treated with tamoxifen 
and fed normal chow (n=4 animals in floxed laminin alpha 5 group, n=8 animals in 
YFP only and floxed beta 1 integrin group). B. Mouse weights from induction to 
harvest, expressed as a percentage change, do not show any effect of genotype. One-
way ANOVA p 0.17. C. Serum bilirubin levels are mildly but statistically 
significantly raised in both of the floxed allele groups. One-way ANOVA p 0.0051. 
D. Serum ALT level is higher in the floxed beta 1 integrin group, although this 
remains within the normal range. One-way ANOVA p 0.013 E. Serum albumin 
levels were higher in both of the floxed allele groups. One-way ANOVA p 0.0026. 
F-H. Examples of YFP staining in the YFP only group (F), floxed laminin alpha 5 
(G) and floxed beta-1 integrin (H) mice. I. Quantification of YFP staining, expressed 
as a total number of YFP-labelled cells per high-powered field, suggests a trend 
towards a reduction in YFP-labelled cells in the floxed laminin alpha 5 group, and an 
increase in the floxed beta 1 integrin group. J. When this is expressed relative to the 
number of biliary epithelial cells (BECs), the reduction in YFP-positive cells in the 
floxed laminin alpha 5 group becomes statistically significant.  
For all of the above analyses, where a significant difference was found using 
ANOVA, Dunnett’s post-test comparison was used to compare each floxed allele to 
the YFP only group, *p<0.05, **<0.01. 
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The effect of floxed alleles on the response to CDE diet 
The CDE diet was used to model hepatocellular injury, using the same induction 
regimen as before. Mice were allowed to recover after the tamoxifen injections and 
then fed CDE diet for 3 weeks prior to harvest, as illustrated in figure 5.4A. 
The genotype of the mice did not have any effect on the change in weight seen in 
response to the diet (figure 5.4B). Similarly, there was no difference in serum 
bilirubin at the end of the diet period (figure 5.4C). 
A marked difference in serum ALT was observed, with significantly higher ALTs in 
the floxed beta-1 integrin group (mean 204 U/L) compared with either the floxed 
laminin group (54 U/L) or YFP only (41 U/L). This suggests a greater degree of 
hepatocellular injury in response to the diet. This was not reflected in any difference 
in the serum albumin (figure 5.4E). 
Initial cell counts suggested a greater number of YFP-positive cells in the floxed 
beta-1 integrin group, with 7.04 cells per HPF compared to 4.84 in the YFP only 
group and 3.53 in the floxed laminin group (figure 5.4F). However, when the number 
of YFP-positive cells were corrected for the number of BECs per section, these 
differences were less marked. There did, however, appear to be a trend towards a 
lower number of recombined cells in the floxed laminin alpha 5 group (21.8% vs 
31.5% and 34.2% in the other groups).  
In CDE diet, the HPCs form cords extending away from the bile ducts and 
infiltrating the parenchyma. In order to distinguish HPCs from biliary epithelial cells, 
I counted the number of YFP-positive cells that were not in contact with a well-
defined lumen. An example is shown in figure 5.4G. This is likely to still include a 
small number of BECs where just the edge of the duct has been caught in the section. 
However, this is likely to give a more accurate reflection of HPCs. Again, there was 
a non-significant reduction in the number of extraductular YFP-labelled cells in the 
floxed laminin alpha 5 group (figure 5.4H). 
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Figure 5.4 Effect of additional floxed alleles on response to CDE 
A. Illustration of experimental timeline for transgenic mice given the CDE diet (n=4 
animals in floxed laminin alpha 5 group, n=8 animals in YFP only and floxed beta 1 
integrin groups). B. Mouse weights from induction to harvest, expressed as a 
percentage change, did not show any difference according to genotype. One-way 
ANOVA p 0.18. C. Serum bilirubin levels were not significantly different between 
groups. One-way ANOVA p 0.56. D. Serum ALT levels were markedly elevated in 
the floxed beta 1 integrin group. One-way ANOVA p 0.0007. E. Serum albumin 
levels were no different between groups. One-way ANOVA p 0.21. F. The absolute 
number of YFP-labelled cells per high powered field was greater in the floxed beta 1 
integrin group; one-way ANOVA p 0.005. G. The number of YFP-labelled cells 
expressed relative to the number of biliary epithelial cells (BECs) did not show any 
significant differences, although there was a trend towards a lower number of 
labelled cells in the floxed laminin alpha 5 group. One-way ANOVA p 0.09. H. 
Example of YFP staining showing BECs clearly associated with a lumen (block 
arrow) and potential HPCs not associated with a lumen (dotted arrow). I. 
Quantification of the number of extraductular YFP cells shows a non-significantly 
lower number in the floxed laminin alpha 5 group.  
Where significant differences were found on one-way ANOVA, Dunnett’s test for 
multiple comparisons was used to compare each floxed allele against the YFP only 
group *p<0.05, ***p<0.001 
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The effect of floxed alleles on the response to DDC diet 
Having demonstrated differences in the liver function tests and a possible (although 
non-significant) difference in the number of recombined cells in response to a 
predominantly hepatocellular injury with CDE diet, I then wanted to look at a model 
of biliary injury. For this, I used the DDC dietary model, as illustrated in figure 5.5A. 
There was no difference in the weight change seen in response to the diet (figure 
5.5B). However, there was a higher bilirubin level in the floxed laminin alpha 5 
group, as shown in figure 5.5C. There was a mean bilirubin of 100.4 µmol/L in the 
floxed laminin alpha 5 group, compared with 40.4 µmol/L in the YFP only group and 
23.0 µmol/L in the floxed beta-1 integrin group (one-way ANOVA p 0.033). This 
may suggest either greater damage or impaired regeneration. 
There was also a significantly higher serum ALT in the floxed laminin alpha 5 group 
(figure 5.5D). The mean ALT in the laminin alpha 5 group was 711 U/L, compared 
with 323 U/L in the YFP only group and 449 U/L in the floxed beta-1 integrin group 
(one-way ANOVA p 0.033). This is suggestive of increased hepatocellular injury 
associated with loss of laminin alpha 5. There was no difference in serum albumin 
between the 3 genotypes (figure 5.5E).   
Quantification of the number of YFP positive cells did not show any difference 
between groups (figure 5.5F). In the DDC diet, the HPCs form ductular structures 
around the portal tracts, rather than the extraductular cords described in CDE. This 
makes it more challenging to distinguish between the original mature bile duct cells 
and newly-formed HPCs. To try to address this, I looked at the number of bile ducts 
containing recombined cells, on the assumption that the mature bile duct cells would 
tend to be restricted to one bile duct per portal tract. This analysis showed 
significantly fewer ducts containing recombined cells in the floxed laminin alpha 5 
group (figure 5.5 G). This would be consistent with a failure of recombined cells to 
migrate to form new ducts.   
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I also looked at the proliferation of recombined cells using dual YFP and Ki67 
staining (figure 5.5 H-I). There is a trend towards lower rates of proliferation with 
both floxed alleles, although this fails to reach statistical significance.  
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Figure 5.5 Effect of additional floxed alleles on response to DDC 
A. Illustration of experimental timeline for transgenic mice given a DDC diet (n=3 
aniamls in floxed laminin alpha 5 group, n=8 animals in YFP only and floxed beta 1 
integrin groups). B. Mouse weights from induction to harvest, expressed as a 
percentage change, were not significantly different between genotypes. One-way 
ANOVA p 0.43. C. Serum bilirubin levels were highest in the floxed laminin alpha 5 
group. One-way ANOVA p 0.033. D. Serum ALT levels were elevated in all groups, 
but were significantly higher in the floxed laminin alpha 5 group. One-way ANOVA 
p 0.033. E. Serum albumin levels were no different between groups. One-way 
ANOVA 0.36. F. Quantification of the number of YFP cells is not different between 
the groups. G. When looking at the number of ducts containing recombined cells, 
however, there is a lower number of ducts containing recombined cells in the floxed 
laminin alpha 5 group. H. Dual immunofluorescence with YFP (green) and Ki67 
(red) to assess proliferation. Original magnification x400, scale bar represents 50 µm. 
I. There is a trend towards lower proliferation in both of the floxed allele groups, 
although this fails to reach statistical significance. n=3 animals per group for the dual 
immunofluorescence analysis. 
Where significant differences were found on one-way ANOVA, Dunnett’s test for 
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Effect on floxed alleles on fibrosis 
As HPC expansion is generally associated with an increase in fibrosis, I looked at the 
the effect of the floxed alleles on fibrosis in the DDC diet. The image analysis for 
these experiments was performed by Alex Raven, using the tissue sections that I had 
generated. I performed the subsequent data analysis myself. 
Both the floxed laminin alpha 5 and floxed beta 1 integrin groups showed 
significantly more fibrosis in response to the DDC diet than the YFP only group 
(figure 5.6A). This was supported by an increase in alpha smooth muscle actin 
(ASMA) staining in the same groups (figure 5.6B), suggesting an increase in the 
number of activated stellate cells.   
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Figure 5.6 Effect of floxed alleles on fibrosis 
Comparison of fibrosis markers in transgenic mice exposed to 2 weeks of DDC diet. 
A. Sirius red staining shows increased fibrosis in those mice with floxed laminin 
alpha 5 or floxed beta-1 integrin genes, compared to mice with the YFP reporter 
alone. One-way ANOVA p<0.001, Dunnett’s post-test correction ***p<0.001. B. 
Alpha smooth muscle actin staining shows an increase in activated stellate cells in 
the two floxed gene groups.   
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Isolation of individual recombined cells using fluorescent reporter 
As recombined cells express YFP, it should be possible to isolate them using 
fluorescence-activated cell sorting (FACS). However, several attempts to isolate cells 
using this method failed to detect any labelling of cells. Representative flow plots are 
shown in figure 5.7A. As recombination could be demonstrated on tissue sections 
using an antibody to amplify the signal, it was felt that the failure to detect 
fluorescent cells on FACS was likely to reflect a weak signal. However, attempts to 
amplify the signal using a fluorescent antibody against GFP were similarly 
unsuccessful (figure 5.7B). This could be explained by the fact that the 
permeabilisation stage required to allow the antibody into the cells may allow the 
YFP to diffuse out. 
A number of new fluorescent proteins have been developed recently with improved 
brightness and photostability relative to YFP (Shaner et al., 2005). I therefore 
decided to use a different fluorescent reporter. tdTomato is an exceptionally bright 
red fluorescent protein developed through directed mutagenesis of the Discosoma-
derived red fluorescent protein, DsRed (Shaner et al., 2004). As with the YFP 
reporter, tdTomato is available as a flox-stop-flox-tdTomato construct that will be 
expressed following Cre expression. The three transgenic mice strains were crossed 
with the tdTomato reporter in place of the YFP. 
Further enhancements to the sorting protocol were the use of FSC gating to select 
singlet cells, and negative selection for CD45 (to exclude haematopoietic cells) and 
7-AAD (to exclude dead cells). Using the brighter reporter and these additional 
criteria, I was able to identify a clear population of fluorescently labelled cells (figure 
5.7C). The FACS experiments in this section were performed in collaboration with 
Wei-Yu Lu. 
Recombined cells were isolated from mice from each of the three genotypes after 
exposure to 2 weeks of DDC diet, and were sent for a gene microarray. It was hoped 
that this would be used for a number of purposes. Firstly, to confirm the loss of 
specific laminin or integrin gene transcription in the floxed groups. Secondly, to 
identify any compensatory changes in other laminin or integrin subunits that may 
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occur secondary to the loss of the floxed alleles. Thirdly, to look for changes in 
intracellular signalling pathways that may be mediating the effects of cell-matrix 
interactions.  
Unfortunately, due to the time taken to re-derive mice with the required genotypes, 
the results of the microarray are not available for inclusion in this thesis but will be 
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Figure 5.7 Isolation of individual recombined cells 
A. Flow cytometry for non-parenchymal cells derived from K19Cre-YFP mice, 
comparing uninduced mice (top panels) with mice given 3 x 4mg tamoxifen to 
induce recombination (bottom panels). Cells were gated for using FSC/SSC (left-
hand panels). There was no discrete identifiable population in the induced mice 
detectable using direct YFP detection (right hand panels). B. Matched flow plots for 
cells from the same experiment, treated with an anti-GFP antibody conjugated to 
APC. There was no discrete identifiable population in the induced mice using this 
approach either. C. Flow cytometry for non-parenchymal cells derived from K19Cre-
tdTomato mice treated with 3 x 4mg tamoxifen. Cells were gated for using FSC/SSC, 
and singlets were selected using FSC-A/FSC-H. Cells that were double-negative for 
CD45 (to exclude haematopoietic cells) and 7-AAD (to exclude dead cells) were 
selected. In this case, a clear population of fluorescent cells are identifiable within 
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5.3 Discussion 
In this chapter, I have examined the effects of loss of either laminin alpha 5 or one of 
the subunits of its potential cell-surface receptors, beta 1 integrin. Each of these was 
knocked out in the adult mouse, targeting this effect to K19-expressing cells which 
will include biliary epithelial cells and HPCs. Unfortunately, these experiments were 
hindered by the need to exclude around half of the animals in the floxed laminin 
alpha 5 group, due to the presence of an additional unexpected Cre. This was only 
detected after completion of the experiments, leading to marked reduction in 
experimental numbers. This increases the risk of type II errors in the analysis, and 
has led me to comment on non-significant trends within this group. Although I am in 
the process of repeating the experiments with more mice from the floxed laminin 
alpha 5 group, the results of these were not ready in time to present in this thesis. 
In the CDE diet, there was little effect of the floxed genes on mouse weight or liver 
function tests. The only significant abnormality was a markedly increased ALT in the 
floxed beta 1 integrin group, suggesting a greater degree of hepatocellular injury. 
This effect was not seen in the floxed laminin alpha 5 group, suggesting that this is 
mediated by loss of signalling from a different matrix component. As beta 1 integrin 
also forms part of both collagen and fibronectin receptors, it is possible that either of 
these matrix proteins may be implicated. There was a non-significant trend towards a 
reduction in the number of labelled cells in the floxed laminin alpha 5 group, 
suggesting a possible role of laminin alpha 5 in cell survival or proliferation. 
In the DDC diet, there were more marked changes in the liver function tests. Mice in 
the floxed laminin alpha 5 group had higher serum bilirubin and ALT levels. 
Although DDC is described as a predominantly biliary injury due to accumulation of 
porphyrins, this can result in secondary hepatocellular damage. It is noteworthy that 
the ALTs were also elevated in the other genotypes on DDC diet, although the 
laminin alpha 5 group had significantly higher levels. There was also a significant 
increase in fibrosis with both of the floxed alleles. 
One of the limitations of this work was the relatively low rate of recombination 
achieved with the K19-CreERT, making it difficult to measure effects on a whole 
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tissue level. Since this work was started, another group have published much more 
efficient recombination in HPCs using an inducible osteopontin-Cre (Espanol-Suner 
et al., 2012) with higher rates of lineage-traced hepatocytes. It is therefore possible 
that combining this osteopontin-Cre with the floxed alleles that I have used would 
provide more accurate results. In particular, it would be very interesting to be able to 
study the effects on differentiation, an event that was seen too infrequently in my 
model to be able to comment on reliably.  
To get around the issue of low recombination rates, I have tried to assess individual 
recombined cells. This makes the assumption that cells that express Cre recombinase 
will be equally efficient in excising the reporter construct and the gene of interest. 
Although this is generally believed to be the case, this has not been demonstrated 
within this work. The awaited gene microarray of sorted cells will allow assessment 
of the efficiency of knock-down of both laminin alpha 5 and beta-1 integrin in the 
tdTomato-expressing cells.   
Another limitation is the poor HPC response to the CDE diet. In both the YFP only 
group and floxed laminin alpha 5 group, the mean serum ALT was only minimally 
raised, suggesting only minor hepatocellular injury. Looking at the YFP only group, 
the number of labelled cells was only slightly higher following CDE than on a 
normal diet (4.8 vs 4.2), suggesting minimal expansion of HPCs with the diet. This is 
supported by the low number of recombined cells that occurred away from a bile 
duct lumen, even in the YFP only group. The very low rates of YFP-labelled 
hepatocytes seen in what was proposed to be a model of hepatocellular regeneration 
are likely to reflect this low rate of injury.  
An alternative dietary model that might be used is the methionine- and choline-
deficient (MCD) diet, with or without ethionine supplementation. In contrast to 
choline deficiency alone, additional methionine deficiency leads to more 
inflammation and fibrosis (Weltman et al., 1996). The MCD diet has the additional 
benefit of being a more clinically relevant model than CDE diet, as it mirrors some 
of the changes seen in human non-alcoholic steatohepatitis (Anstee and Goldin, 
2006). It has been shown that methionine counteracts the effects of ethionine in a 
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choline-deficient diet (Sidransky and Verney, 1969). The combination of 
methionine- and choline-deficiency with ethionine supplementation (MCDE) 
produces significant HPC expansion (Jung et al., 2010, Huch et al., 2013). 
A more robust HPC response was seen with the DDC diet. In this model, the effects 
on hepatocellular injury and fibrosis are intriguing. Although HPCs have been 
extensively studied with regard to their ability to form hepatocytes, it is only very 
recently that it has been suggested that they may play a role in modulating liver 
injury. A recent study showed that isoproterenol (a non-selective beta-adrenergic 
agonist) both stimulates HPC numbers and protects against acetaminophen-induced 
liver injury (Soeda et al., 2014). In vitro studies suggest that this effect may be 
mediated by increased expression of HPC-derived Wnt ligands on hepatocyte 
survival, and transplantation of HPCs also improved liver injury. It is possible that 
HPCs have a role in protecting against hepatocellular injury and that loss of laminin 
alpha 5 impairs this.  
The increased fibrosis seen in the floxed laminin alpha 5 group may reflect the 
increased injury, or may due to altered signalling between HPCs and stellate cells, or 
a combination of both. In the case of the floxed beta 1 integrin group, the increase in 
fibrosis occurred in the absence of any change in ALT levels, suggesting that this 
effect is more likely to be a result of altered signalling to stellates. 
In spite of the difficulties encountered during the transgenic experiments due to 
reduced experimental numbers, these results do suggest an altered regenerative 
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Chapter 6: Concluding remarks and future 
directions 
 
The relationship between HPCs and extracellular laminins is well-recognised but 
incompletely understood. One factor that has often been overlooked is the 
heterogeneity within the laminin family. In this thesis, I have examined the changes 
in individual laminin alpha chains and shown a marked upregulation of laminin alpha 
5 in two separate models of HPC expansion. This co-localises with the HPCs and 
appears to be produced predominantly by the progenitor cells themselves. Laminin 
alpha 5 is also shown in human liver disease associated with ductular reactions. The 
HPCs express the laminin-binding α6β1 integrin. 
A series of in vitro experiments showed that laminin alpha 5-containing matrix 
promotes adhesion, spreading and migration of an HPC cell line. These effects are 
only partially blocked by antibodies targeting beta-1 integrin, a subunit common to a 
number of laminin-binding cell surface receptors. Disruption of endogenous laminin 
alpha 5 synthesis using siRNA causes a reduction in proliferation and resulted in 
differentiation towards a more hepatocyte-like phenotype. This suggests that laminin 
alpha 5 plays an important role in autocrine signalling amongst HPCs. 
Lastly, loss of laminin alpha 5 in vivo modulates the response to HPC expansion, 
with an increase in hepatocellular injury and fibrosis in the DDC model. Loss of 
beta-1 integrin on the HPCs does not recapitulate all of these effects. This, along 
with the in vitro data, suggests that cell surface receptors other than integrins 
containing the beta-1 subunit are important in the interaction between HPCs and 
extracellular laminin alpha 5. This work opens up a number of exciting avenues for 
research. 
I selected beta-1 integrin to study because of its occurrence in a number of the 
laminin-binding receptors but there are other integrins (α6β4) and non-integrin 
receptors (dystroglycan, syndecans and Lutheran blood group glycoprotein/BCAM) 
that may be mediating this interaction (Kikkawa et al., 2000, Tani et al., 1999, 
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Shimizu et al., 1999, El Nemer et al., 1998). Lutheran/BCAM is the most appealing 
of these, due to its high specificity for laminin alpha 5. It would be interesting to 
explore the expression of Lutheran/BCAM on HPCs during the models I have 
already used. If a correlation with HPC expansion is seen, there are Lutheran/BCAM 
knock-out and transgenic overexpressing mice that could be used to study the effects 
of altered signalling through this receptor (Moulson et al., 2001). Alternatively, it 
may be that co-signalling through other receptors, such as the tetraspanins, is 
important in modulating integrin signalling. 
Throughout my thesis, I have focussed on the synthesis of matrix. However, it is 
important to remember that the extracellular matrix is dynamic and that degradation 
can play a role too. It is known that the laminin seen in association with HPC 
expansion is transient but there is little work on the regulation of laminin degradation 
in the liver. Much of the work on matrix remodelling in the liver has focussed on 
collagen turnover (Hemmann et al., 2007) but an improved understanding of the role 
of specific MMPs and TIMPs in regulating specific laminin isoforms may also 
identify further potential targets to enhance regeneration.  
I have also focussed in my work on cell behaviour, rather than on the signalling 
pathways that lead to this. A further direction for study would be to identify the key 
intracellular regulators of the effects of laminin alpha 5. During embryonic 
development, laminin-511 is required for hair morphogenesis. It has been shown that 
laminin-511-null mice fail to express noggin (Gao et al., 2008). Noggin is an 
inhibitor of bone morphogenetic protein (BMP) which causes expression and 
activation of members of the Lef-1/TCF DNA-binding protein family, and 
subsequently activates Sonic hedgehog (Shh) signalling and down-regulates E-
cadherin. Exogenous noggin or Shh were able to restore normal hair follicle 
development. In contrast, laminin-111 did not trigger noggin expression. Shh 
signalling has been shown to influence HPC behaviour and is a strong potential 
candidate for mediating the cell-matrix effect (Omenetti et al., 2011).    
Work in embryonic intestinal tissue derived from Lama5 deficient mice has also 
identified marked changes in Wnt and PI3K/Akt signalling (Ritie et al., 2012). Cell 
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culture experiments suggest that laminin-511 inhibits Wnt signalling and stimulates 
the PI3K/Akt pathway. Cell polarity is important in both the regulation of stem cells 
and in the maintenance of epithelial functions, and laminins play a role in cell 
polarization (Li et al., 2003b). 
It is not clear how the matrix-derived signals are integrated with the currently 
identified signalling pathways involved in HPC regulation (Santoni-Rugiu et al., 
2005, Boulter et al., 2012). Further work is required to assess the interplay between 
laminin-511 and the influences of TWEAK, Wnt, Notch and Shh signalling. Co-
culture experiments may be informative in assessing the interaction between cell-
matrix and cell-cell signalling. 
The effect of loss of laminin alpha 5 on both liver injury and fibrosis are also 
exciting findings. Although HPC expansion has recently been shown to be associated 
with a reduction in acute liver injury by Soeda et al (2014), my work provides further 
support to this novel concept.  
By further understanding the role of the extracellular matrix in regulating HPC 
behaviour, we may hopefully be able to design more rational targeted therapies to 
influence both fibrosis and regeneration. As laminin-511 is widely distributed 
throughout adult epithelial and endothelial tissues, systemic therapies to alter 
expression levels are unlikely to be appropriate. However, a detailed understanding 
of the cell-matrix interaction may offer a more specific therapeutic target. 
Furthermore, any anti-fibrotic therapies should be assessed with regard to their effect 
on laminin isoform distribution to avoid any unwanted effect on HPCs. 
A number of forms of cell therapy have been proposed for chronic liver disease, 
including bone marrow-derived cells, stem cells (ES and iPS-derived) and HPCs 
(Piscaglia et al., 2010, Lanthier et al., 2013). Extracellular matrix is likely to play an 
important role in the engraftment of any such exogenous cells. There is some 
evidence to suggest that laminin promotes the adhesion of bone marrow-derived stem 
cells in the liver following partial hepatectomy, although this work did not assess 
individual laminin isoforms (Carvalho et al., 2008). I would speculate that laminin 
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alpha 5-containing matrix is likely to be important in the engraftment of HPCs during 
cell therapy. My results also suggest that laminin-511 is likely to be beneficial for the 
ex vivo expansion of HPCs for any such cell therapy. 
Macrophage cell therapy has been shown to result in increased expression of MMP-9 
and MMP-13 within the liver, with an accompanying reduction in fibrosis and 
expansion of HPCs (Thomas et al., 2011). This demonstrates the potential for 
manipulation of matrix turnover, and an ability to influence laminin alpha 5 levels 
may have important implications for regeneration.  
In conclusion, this work is the first description of the changes in laminin alpha chains 
during models of HPC expansion and identifies laminin alpha 5 as the predominant 
isoform. Laminin alpha 5 has significant autocrine effects on HPC behaviour in 
culture, and knock-down of laminin alpha 5 in K19-expressing HPCs produces an 
increase in liver injury and fibrosis in response to the DDC diet. 
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